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3. THESIS AT A GLANCE
Questions Materials /
Methods
Results Conclusion
I Can a
laparoscopic
approach
provide good
outcomes for
both benign and
malignant liver
lesions?
Are there
benefits of
anatomic
resections?
139 patients (113
with malignant and
27 with benign
lesions), 147
procedures, 176
laparoscopic liver
resections.
38 pure anatomic
resections and 102
pure non-anatomic
resections.
Conversions - 3.4%,
blood loss 200 and 400
ml, operative time 148
and 180 min, respectively,
for benign and malignant
lesions.
Blood loss 300 and 350
ml, operative time 185
and 145 min, respectively
for benign and malignant
lesions.
Intraoperative incidents -
7%, postoperative
complications - 14.3 %
(similar in all subgroups).
Postoperative stay - 3
days. Mortality - 0.7%.
Procedures peryear
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Lapa
Open
Procedure
flowchart
In experienced
hands,
laparoscopic liver
resection is a
favourable
alternative to
open resection.
Perioperative
morbidity and
mortalityappear
to be comparable
to those of open
resections.
Anatomic
resections are not
associated with
any benefits.
II Does
laparoscopic
liver resection
for colorectal
liver metastases
provide good
oncologic
outcomes?
107 patients, 118
procedures, 146
laparoscopic liver
resections.
Mean Fong score -
1.8. Mean
Basingstoke
Predictive index
(BPI) - 7.
Conversions - 4.2%,
blood loss - 300 ml,
operative time - 188 min.
R0 resection - 93%.
Postoperative
complications - 14%.
5 year survival - 51%
(10% and 7% over the
values calculated from
Fong score and BPI
respectively)
Patient
Postoperative
flowchart
Survival
Oncologic
outcome
including long-
term survival is
comparable to or
better than that of
open surgery; the
observed
actuarial survival
is better than
expected by
Fong’s BPI
scoring systems.
III Is laparoscopic
approach an
appropriate
method for
repeat liver
resection?
76 laparoscopic
repeated liver
resections were
attempted.
Operative
indications were
metastasis (63),
hepatocellular
carcinoma (3), and
benign tumours
(10).
Conversions - 11%,
blood loss - 300 ml,
operative time - 180 min.
R0 resection - 92%.
Postoperative
complications - 26%,
including 8% of major
complications.
5 year survival - 55%
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Laparoscopic
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Questions Materials /
Methods
Results Conclusion
IV Does
laparoscopic
liver resection
for
posterosuperior
segments
provide
similarly good
outcomes like
for anterolateral
segments?
75 patients who
underwent
primary minor
single liver
resection for
malignant
tumours affecting
either
posterosuperior
segments (1, 7, 8,
4a; group 1) or
anterolateral
segments (2, 3, 5,
6, and 4b; group
2).
Perioperative and
oncologic outcome did
not differ between the
groups: Operative time
- 127 min, blood loss -
200 min, postoperative
hospital stay - 2 days.
R0 resection - 95%.
Resection margin was
the only parameter that
differed significantly
between the studied
groups (median 3
versus 8 mm).
Review of liver
segments
Approach to
segment 8
Appropriate
adjustment of
surgical techniques,
equipment and
patient positioning
enables safe and
effective
laparoscopic
resections for lesions
located in both
posterosuperior and
anterolateral
segments.
V Can
extracorporeal
MR guided
HIFU system
provide precise,
and safe
ablation of the
liver resulting in
irreversible
tissue damage?
13 Norwegian
local swine (25-
45 kg) were used
for research
analysis.
7 swine – HIFU-
ablation in acute
experiment, 6
swine – HIFU
ablation in
survival
experiment
(survived 1 week
after HIFU-
ablation).Applied
power 120-350 W.
There was good
correlation between
the zone of planned
ablation, radiologic
and histopathologic
findings.
Histopathology
confirmed only minor
reversible alterations in
acute series.
Survival series
revealed higher degree
of histopathologic
alterations,
nevertheless only
multi-cycle regime
with power of 350W
resulted in coagulative
necrosis of the liver
tissue. The latter
regime resulted in
larger ablation volume
than planned due to
observed cavitation.
Experimental
swine
Macroscopic picture
after ablation in
acute series
Coagulative necrosis
MR-guided HIFU
ablation in the liver is
a challenging
ablation modality
due to the high
vascularity of liver
parenchyma. Upon
application of high
energy protocol (350
W), it is feasible to
achieve complete
ablation of liver
tissue verified by
structural
histopathology.
Impact of multi-
cycle protocol, issues
of functional analysis
of irreversible tissue
damage and
threshold to
cavitation onset
require further
studies in order to
optimise HIFU
ablation of the liver.
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4. INTRODUCTION
“When the liver is wounded, much blood comes out”
Ambrose Pare1
4.1 Open liver resection
One may go back centuries to spot critical developments in the history of medicine that
prompted the birth and development of liver surgery. The history of liver surgery can be
divided into four periods.2,3
During the first period, from ancient times until end of the 19th century, liver anatomy was the
main area of concern. The legend of Prometheus, written by Hesoid (750–700 BC), recounts
ancient times.4 Prometheus stole fire from Zeus, the godfather of ancient Greece, and gave it
to human beings. For this violation, Zeus chained him to a rock and sent an eagle to devour
his liver (Illustration 1). The liver regenerated and grew back to its normal size overnight.
Each morning the hungry eagle returned, and Prometheus was captured in perpetual pain.
Nowadays the astonishing regenerative capacity of the liver is no longer an inspiration for
mythical tales, but is the basis for contemporary liver surgery.
Illustration 1: Detail from Prometheus Bound, by Peter Paul Rubens, 1612–8, the
Philadelphia Museum of Art.
The Ancient Egyptian physician Herophilus from Alexandria (330–280 BC) was one of the
first anatomists who described the liver, although his written work no longer remains. The
Greek physician Galen (AD 130–200) referred to his work and described the lobar anatomy
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and vasculature, interpreting the liver as the source of blood. However, in the subsequent
centuries of the Middle Ages, knowledge on liver anatomy moved forward very little.
In the 17th century, anatomists started exploring hepatic anatomy with bright ideas. In 1654,
the English physician Glisson cooked the liver, removed the liver parenchyma, and explored
the hepatic blood flow with dye (illustration 2).5 He described the intrahepatic anatomy and
topography of the vasculature. Glisson’s work was forgotten for over 200 years. Later, in the
late 19th century, several authors published studies on liver anatomy, all built on Glisson’s
publications.6 In 1888, the German physician Hugo Rex and in 1897, the English physician
James Cantlie challenged the accepted anatomic division of the liver.7,8 They proposed a
division line drawn from the top of the gallbladder and back towards the caval vein.
Illustration 2: Intrahepatic vasculature (From Glisson F. Anatomia hepatis. London: Dugard;
1654).
The growing understanding of liver anatomy was one of the substantial prerequisites for the
development of liver surgery. However, it was still far from realisation, and the liver remained
a fragile bleeding mystery. Only anecdotal records of liver surgery existed; these were
typically reports about the removal of protruding liver tissue after injury. Among the reporting
surgeons were Ambroise Pare from France, J.C. Massie from USA, and Victor von Bruns
from Germany.9 However, hepatic trauma at that time was generally managed without
surgery.
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The second period lasted from the end of the 19th century to the 1940s. In the 19th century,
two fundamental concepts enabling major surgery were introduced: anaesthesia and asepsis.
In 1842, Crawford W. Long used ether as a surgical anaesthetic for the first time in the USA.
In 1867, Joseph Lister from Scotland introduced antiseptic techniques against bacterial
infections after Louis Pasteur from France had discovered the dangers of bacteria.
This was the time of the first successful resections. Liver resections were performed and
reported in many centres around the world. However, the outcomes were too dismal and
complications following the use of mattress sutures were too high. Resections could not be
performed any other way, however, without any tools to visualise the liver, and without blood
banks and intensive care units. Carl Langenbuch, from Germany, performed the first
cholecystectomy; he reported the first elective and successful liver resection in 1888.10 In
1891, William W. Keen from the USA performed the first resection in the USA.9 He used the
‘‘finger fracture’’ technique to divide the liver parenchyma. However, intraoperative bleeding
control remained the most striking challenge. In 1896, Michel Kousnetzoff and Jules Pensky
suggested the use of a continuous mattress suture above the resection line for controlling
bleeding.11 In 1908, Pringle from Scotland, described a method using temporary compression
of the portal ligament.12
It was once more the excellent work of anatomists that provided the key insights to overcome
major bleeding. In 1888, Hugo Rex, from Germany, and in 1897, James Cantlie, from
England, challenged the established approach to anatomic division of the liver by the
falciform ligament.7,8 They separated the liver by the branches of the portal vein in corrosion
studies. Also, they defined an avascular plane through the gallbladder bed toward the vena
cava and through the right axis of the caudate lobe along the middle hepatic vein. At present,
this plane is known as the Rex-Cantlie line. At the beginning of the twentieth century, Walter
Wendell, from Germany, and Hansvon Haberer, from Austria, were the first surgeons to
perform resections along this anatomic plane.13,14
The third period lasted from the 1940s to the mid-1990s. The experience which had been
gained during World War II had a huge initial impact on the further development of liver
surgery; however, the development of anaesthesiology, imaging and safe surgical techniques
essentially contributed to this development.
Essentially due to the work of the French surgeon and anatomist Claude Couinaud, the
anatomy of the liver has become clearer.15-17 He studied the anatomy by means of casting the
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vascular and biliary structures of the liver. Couinaud finally defined liver anatomy from the
vascular structures serving each area of the organ. His suggestion of dividing the liver into
eight segments according to the portal vein and venous branching is the segment definition
that most liver surgeons use today (Illustration 3).18
The first planned pure anatomic liver resection is credited to Lortat-Jacob, who performed a
right lobectomy as treatment for metastatic colon cancer in 1952.19,20
Several factors combined to allow the resurgence of operations on the liver that began around
1950. First, the lessons of World War II in handling liver trauma increased our confidence in
the control of bleeding. Second, more attention was paid to inflow and outflow control, with
the specific ligation of vessels gradually replacing grosser techniques as a result of the work
of Couinaud, Hjortsjo, Goldsmith, Woodburne, Healey and colleagues.15,16,21-23 Third, the
ability to carry a patient through a difficult operation increased exponentially with advances in
metabolic, haemodynamic, and respiratory support. Fourth, liver imaging has undergone
major improvements in the last 30 years. Finally, Hugh Edmondson determined the pathology
of these rare tumours by collecting cases from many sources.24
Due to careful attention paid to biliary and especially vascular anatomy of the inflow and
outflow tracts, major liver resections came to have acceptable morbidity and mortality levels
and were, therefore, often used. The total number of liver resections increased dramatically
during those years.
Illustration 3: Liver segments, frontal view.
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The fourth and present period started from the mid-1990s. This period was impacted by
tremendous progress in surgical and especially laparoscopic instrumentation25 and the concept
of multimodal treatment.26
This period is characterised by: 1) The popularisation of parenchyma-sparing techniques,
which became possible due to the introduction of principally new surgical instrumentation
based on ultrasound, coagulation and stapling principles enabling the provision of safe non-
anatomic parenchyma-sparing multiple resections instead of major resections;27,28 2) The
increased application of minimally invasive modalities: laparoscopic surgery and ablative
modalities;29 3) The wide application of adjuvant and neoadjuvant chemotherapy with regard
to colorectal liver metastases;30 and 4) Spreading of unilateral embolisation or ligation of the
portal vein inducing hypertrophy of the future liver remnant and therefore enabling the
resection of many borderline liver tumours.31
The indications for surgery in liver metastases of colorectal cancer and also for hepatocellular
cancer and cholangiocarcinoma have expanded considerably in this period.32 As the number
of liver transplants considerably increased, transplantation became a competitor to liver
resection in regard to hepatocellular cancer and cholangiocarcinoma.33
4.2 Minimally invasive techniques
Birth of laparoscopic liver resection
In the beginning of the 1980s, Kurt Semm from Germany performed the first laparoscopic
appendectomy34, and in the mid-1980s, Eric Mühe from Germany and Philippe Mouret from
France reported pilot cases оf laparoscopic and videolaparoscopic cholecystectomy,
respectively35,36. The introduction of these procedures announced a revolution in
gastrointestinal surgery. In 1991, Harry Reich and colleagues from the USA, and, in 1992,
Michel Gagner and colleagues from Canada/USA reported the first cases of laparoscopic liver
resection.37,38 At that time, Gagner’s report was only considered as a poster presentation at the
congress of the Society of American Gastrointestinal Endoscopic Surgeons; since that time,
the feasibility and safety of this procedure have been documented in several reports.27,39-53
However, in contrast to the general surgery, the advancement of laparoscopic surgery was not
so swift in regard to liver surgery, especially concerning malign lesions.54
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In spite of the apparent progress of laparoscopic hepatobiliary surgery, many hepatobiliary
surgeons are still very cautious in regard to the wide application of these advanced
techniques.55 It relates to poor knowledge about long-term outcomes of such procedures as
well as to challenges which have been met by surgeons as a way of mastering this technique.55
Recently, several technological solutions have been suggested to decrease the technical
challenges of the laparoscopic approach and enable its easier introduction in centres lacking
surgeons with exceptional laparoscopic technical skills, i.e. promoting the rapid introduction
of laparoscopic techniques at ordinary departments of hepatopancreatobiliary surgery
worldwide. Robotic assistance and on-line image guidance based on the three-dimensional
reconstruction of preoperative imaging presents typical examples of such modalities.56-59
However, the role of these innovations are still disputable.
Topical problems
In Norway, the most frequent liver neoplasms evaluated for surgical treatment are colorectal
metastases.60 Surgical resection has so far been considered the only treatment to offer
prolonged survival to patients with primary or metastatic cancer confined to the liver.61
Patients suitable for hepatic resection have shown quite good 5-year survival rates after
operation, ranging from 30% to 55%.62-64
The well-established open approach is associated with high surgical trauma.65 The
introduction of laparoscopic liver resection has been taken with high expectations.53,66,67 The
attraction of laparoscopic liver resection is that it has the potential for more rapid recovery
from surgical trauma. This results in a shorter hospital stay, less postoperative pain, less
postoperative morbidity, an earlier return to normal activities, and economic benefits
compared to the open approach.68,69 Use of the laparoscopic technique has been reported for a
range of liver disorders; this technique even played a role in harvesting of the living donor
liver for transplantation.70,71 This technique has also been used in an increasing proportion of
patients in leading institutions. If in earlier years the laparoscopic approach was mainly
considered for minor wedge liver resection,72 all types of liver resections are currently
reported and in expert centres indications to laparoscopic liver resection is largely the same as
to open liver resection (except very bulky tumours and necessity for vessel/bile duct
reconstruction).73
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However, patients operated on for malignant liver lesions represent special concerns, such as
the uncertainty of oncological outcomes. Preliminary studies in laparoscopic surgery suggest
the feasibility of the achievement of similar levels of oncological radicalism.74 There are poor
data in regard to late oncological outcomes of laparoscopic liver resection.75,76
Repeat liver resections due to tumour recurrence has been proven to be an effective treatment
option.77,78 Its aspects would gain new challenges with the introduction of laparoscopic
techniques. This may be expected due to the lower occurrence of adhesion development after
the laparoscopic procedure,79 which would facilitate subsequent repeat liver resection.  This
could contribute to the better survival of patients with liver malignancies.
Laparoscopic resection for easily accessible superficial liver segments have been relatively
rapidly adapted in clinical routine in many hepatopancreatobiliary centres worldwide.80
However, it has been a discord in surgeons’ opinions on the approach to liver segments that
are laparoscopically difficult accessible and challenging (the so-called posteriosuperior
segments). The accumulation of experience and the introduction of new surgical
armamentarium appears to resolve this problem.81,82
The volume of necessary resection was very disputable in the era of open surgery;28,83 the
introduction of laparoscopic techniques has added a new focus on this topic due to the new
paradigm of operative tactics. A steady tendency to parenchyma-sparing resections observed
in the last decade will go through the trial in laparoscopic epoch.84
Some problems still remain regarding the final preoperative diagnosis of liver lesions in spite
of the enormous progress of both imaging modalities and tumour marker research.85,86 In
particular, small tumours of the liver or bile ducts still represent a clinical challenge, though
the detection rate of these tumours by radiological and other methods has essentially
improved. Medicine is not perfect at distinguishing intrabiliary malignancies from benign
strictures, and this enigma has not been resolved by years of experience with intrabiliary
endoscopy, computerised tomography (CT), magnetic resonance imaging (MRI) and positron
emission tomography (PET).87 Fine-needle aspiration biopsy has been largely abandoned due
to the unacceptable rate of tumour dissemination.88
In the past, mistaken preoperative diagnosis has resulted in unnecessary laparotomy and liver
resection, which could have considerable consequences for patients. Nowadays, the
application of laparoscopic approaches in cases of mistaken preoperative diagnosis of liver
disease substantially lessens the negative consequences of such faults.
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Research in genetics could potentially contribute to this issue;89 conceivably, the future will
enable asymptomatic benign tumours to be diagnosed with sufficient accuracy to make
surgery and ablation superfluous.
Ablative modalities, extracorporeal high intensity focused ultrasound
The majority of patients with hepatic malignancy have disease that is not amenable to surgical
resection.90 This, and a high incidence of new liver metastases following the successful
resection of metastases (60%–80%), has spurred interest in therapeutic alternatives. 91
Image-guided tumour ablation is consigned to a group of treatment methods introduced in the
last two decades that have been deemed important tools in the treatment of a wide range of
tumours.92 Malignancies in the liver and kidneys are most often indications for ablative
treatment.93 Among the different options, radiofrequency ablation, laser ablation and
cryoablation have gained highest popularity94-96. However, these methods are still associated
with a high risk of tumour recurrences.
Ultrasound technology has allowed the utilisation of focused ultrasound energy for
therapeutic aims such as tissue ablation. High intensity focused ultrasound (HIFU) is a
recently introduced ablative modality with growing popularity.97,98 Distinct to radiofrequency
or cryoablation, ultrasound is entirely non-invasive and can be applied to tumours that are
deep within the body, provided that there is an acoustic window to enable the transmission of
ultrasound energy.
The physical principals of HIFU were first described by Wood and Loomis in 1927.99 In the
middle of the 1930s Lynn and co-workers started the first animal experiments using HIFU to
treat liver tumours; however, the absence of visualisation tools at that time limited the
development and practical application of HIFU.100 Interest in HIFU has recently revived
together with the establishment of three-dimensional imaging.101 While ultrasound-guided
HIFU ablation of the liver has already been introduced in several centres worldwide,102-105 the
MR-guided HIFU ablation is still performed only in experimental laboratories.106,107 A reason
for that could be challenges due to the more complicated MR equipment required for
procedural on-line control.
HIFU with ultrasound has restricted the target definition and monitoring capability of the
ablation procedure. Combining MRI with multiple-element phased-array transducers to create
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MR-guided focused ultrasound thermal therapy provides more accurate targeting and real-
time temperature monitoring.108 The site and shape of the lesion can be predetermined, each
sonication is delivered within a few seconds, and lesions are very sharply defined.109 HIFU
could be potentially performed without general anaesthesia; there is no risk of tumour seeding
in needle tracks.110,111
Despite the wealth of research in the field of HIFU, its application as a non-invasive surgical
tool is still in its infancy. Experimental and clinical research is required to further investigate
and improve its safety and efficacy in the treatment of liver malignancies.
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5. AIMS OF THE STUDY
General aim:
The main goal of this thesis was to estimate and develop new minimally invasive techniques
in the treatment of patients with lesions in the liver: laparoscopy and HIFU.
Specific aims:
 A. Evaluate perioperative outcomes of laparoscopic liver resection based on large volume
single centre material.
 B. Evaluate surgical and late oncologic outcomes after laparoscopic liver resection for
colorectal metastases.
 C. Evaluate laparoscopic repeat liver resection after laparoscopic or open primary liver
resection.
 D. Evaluate laparoscopic liver resection for lesions located in easily and difficult accessible
segments.
 E. Establish and develop experimental an in vivo swine model for HIFU ablation of the
liver.
 F. Evaluate the safety and efficacy of MR-guided HIFU to ablate liver parenchyma in an in
vivo swine model.
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6. MATERIAL
6.1 Patients
Two hundred and twenty patients who underwent laparoscopic liver resection during 244
procedures from August 1998 to December 2010 at the Oslo University Hospital,
Rikshospitalet formed the research basis for the clinical section of this thesis.
Clinical data were collected from patient journals and registered in an MS Excel database
established in 2000. Subsequently, the database was prospectively updated, except for the
period 2005 to 2006 when data were retrieved retrospectively.
Paper 3 also included 47 patients operated upon in partner institutions (31 patients in the
Institut Mutualiste Montsouris, Paris, France and 16 patients in the University of Louisville,
Louisville, USA).
Protocols for the clinical studies have been approved by the Institutional Patient Ombudsman
and the Regional Ethic Committee (Helse Sør-Øst).
6.2 Experimental animals
Thirteen male Norwegian land swine with a median body weight of 31 kg (range 25-45.5 kg),
who were treated on the liver by the Sonalleve HIFU system under guidelines of 3 Tesla
Achieva MR scanner (Philips Healthcare) from April 2010 to March 2011 at the Intervention
Centre, the Oslo University Hospital, Rikshospitalet, formed the research basis for the
experimental part of this thesis.
Research data were collected and registered in an MS Excel database.
The protocol for the experimental study was approved by the National Animal Research
authority.
.
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7 METHODS
7.1 Laparoscopic technique
Pneumoperitoneum was established by an open technique, and intraabdominal carbon dioxide
gas pressure was set at 8 to 10 mm Hg. A 30° laparoscope (Olympus, Tokyo, Japan) and 5-
and 12-mm trocars (Tyco/Covidien, Norwalk, Connecticut, USA) were used. In very difficult
cases (e.g., when the quality of the liver parenchyma prevented adequate mobilisation of the
right lobe), a flexible laparoscope (HD EndoEYE LTFVH; Olympus, Tokyo, Japan) was used.
The number of trocars depended on the lesion location and the patient’s body build, but
usually numbered 3 to 5. For lesions located laterally and posteriorly on the right side, the
patients were placed in a lateral position with the right abdominal side elevated between 30°
and 60°. Patient positioning and trocar placement was carefully adjusted to suit the tumour
location and patient constitution.
A diagnostic and staging laparoscopy was performed first. Intraabdominal adhesions due to
previous surgeries were treated in most of the patients. The liver was thereafter thoroughly
examined using laparoscopic ultrasonography (Hitachi Medical Corp, Aloka Inc, Tokyo and
SonoDoppler; Sintef Helse/Mison, Trondheim, Norway) with Doppler function.
The resection line was marked at the liver surface by electrocautery following
ultrasonographic examination to locate the tumour. The capsule was divided by use of
ultrasound scissors (Autosonics [Tyco/Covidien], SonoSurge [Olympus]), or Harmonic
scalpel (Ethicon Endo-Surgery, Cincinnati, Ohio, USA).
Parenchymal transection was performed mainly by either an ultrasound surgical aspirator
(applied trademarks – SonoSurg Aspirator, CUSA or Selector) or a bipolar coagulator
Ligasure. Clips were used for vessel transection. Endo-GIA (US Surgical Corporation,
Norwalk) was applied only for transection of major vessels, mainly during formal
hemihepatectomies. Ultrasonic scissors were seldom applied for parenchymal transaction.
The resections were guided by repeated ultrasonography for the exact location of the tumour.
Meticulous dissection ensured that vessels and bile ducts were safely secured. The Pringle
manoeuvre was not applied. During left and right hemihepatectomies, we used
extraparenchymal and transparenchymal techniques to divide the hepatic vessels and biliary
ducts. Procedures were routinely performed by fully laparoscopic techniques; a hand-assisted
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technique was applied in very few cases to avoid conversion to open surgery. The resected
liver was removed in one piece through an enlarged umbilical port incision, using a 15-mm
pouch (Endo Catch; US Surgical Corporation). An abdominal drain was used in only a few
cases.
7.2 Standardisation tool for outcome evaluation
Minimally invasive liver surgery has a history of about 20 years; however, up to the mid-
2000s only a small proportion of liver surgeries were done laparoscopically.84
The Oslo University Hospital is one of the leading centres worldwide in the area of
laparoscopic liver surgery, both related to the number of cases, outcomes and relatively early
introduction in 1998. Having this starting point we have made a comprehensive review of the
existing systems for standardised reporting of surgical outcomes and perioperative morbidity.
This was urgent because our study was not intended to be comparative; thus, standardisation
was considered as the only way to achieve objective data which would be valid for application
by surgeons and researchers from different parts of the world.
Firstly, we have chosen to apply the registration of both intent-to-treat and per protocol
outcome. This required only a small amount of extra time, but gave a quite comprehensive
picture of surgical outcome. Perioperative adverse events were naturally recorded by the
intent-to-treat manner.
Secondly, we have purposefully reviewed a huge number of international papers reporting
large surgical materials with a focus on the analysis of perioperative mortality. The simple 3
grade classification of surgical errors developed by Satava in 2005 took our attention as a
model for standardisation of intraoperative unfavourable incidents.112 A classification of
postoperative complications originally developed by Clavien, Sanabria and Strasberg in 1992
and later revised by Dindo, Demartines and Clavien in 2004, by Strasberg, Linehan and
Hawkins in 2009, and by Porembka, Hall, Hirbe and Strasbergin in 2010 (Clavien-Dindo-
Strasberg classification), was chosen to standardise the reporting of postoperative
complications.113-116
Later on, we developed our own approach to grade perioperative adverse events.82,117,118 This
incorporates our own classification of intraoperative unfavourable incidents based on the
Satava principles and the modified Accordion classification (the last version of the Clavien-
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Dindo-Strasberg classification).112,116 Schematic reproduction of the constituents of
perioperative adverse events are presented in Illustration 4. Table 1 presents the classification
of intraoperative unfavourable events and Table 2 shows the classification of postoperative
complications.
Illustration 4: Schematic reproduction of the constituents of perioperative adverse events.
Table 1: Own classification of intraoperative unfavourable incidents elaborated from the
Satava approach to grade surgical errors.
Grade Definition of intraoperative incidents
I Incidents managed without a change of operative approach and without further
consequences for the patient. This includes minor injury of adherent or adjacent
organs and minimal changes of intraoperative tactics and cases with blood loss
over the normal range.A
II Incidents with further consequences for the patient. This includes cases requiring
limited resection of intraoperatively injured organs or cases with blood loss
which is appreciably over the normal range.B For laparoscopic/thoracoscopic/
endoscopic surgery it includes intraoperative incidents requiring conversion.
III Incidents leading to significant consequences for the patient.
A corresponds to blood loss over 1000 ml in cases of liver resection.
B corresponds to blood loss over 2000 ml in cases of liver resection
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Table 2: The modified Accordion classification of postoperative complications, the Oslo
revision. Text marked by bold italic type presents the modified points in the classification.
GradeA Definition of postoperative complication
I Requires only minor invasive procedures that can be done at the bedside, such as the
insertion of intravenous lines, urinary catheters, and nasogastric tubes, and drainage
of wound infections. Physiotherapy and anti-emetics, antipyretics, analgesics,
diuretics, electrolytes, and physiotherapy are permitted. It includes cases requiring
a doubly prolonged postoperative stayB to treat conditions which are otherwise
considered as sequel.
II Requires pharmacologic treatment with drugs other than such allowed for minor
complications, e.g., antibiotics. Postoperative blood transfusions and total parenteral
nutrition are also included.
III No general anaesthesia: requires management by an endoscopic, interventional
procedure or reoperation without general anaesthesiaD.
IV General anaesthesia or single-organ failure.
V General anaesthesia and single organ failure or multisystem organ failure ( 2 organ
systems).
VI Death within 30 postoperative days or up to discharge if the patient stays longer in
the hospital.
A Minor complications: Grade I-III, Major complications: Grade IV-VI
B Median hospital stay for that disease and procedure which is present in the particular institution is
to be applied as a reference value.
C Need for artificial pulmonary ventilation during patient anaesthesia is a boundary to define
general anaesthesia.
D Cases when an intervention was performed due to the suspicion of complication (without its
confirmation) are not to be regarded as a basis for severity grading. However, such cases should be
reported (see examples in the text).
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7.3 Experimental HIFU treatment
HIFU Equipment
The Sonalleve MR-HIFU platform from Philips Healthcare integrated to the bed of a 3 Tesla
MR Achieva scanner was applied.
Ex vivo porcine models
Prior to animal studies, we had to learn procedures initially on the phantom model and later
on an ex vivo porcine model. The experience from these procedures was quite inspiring,
showing coagulation of muscular tissues.
Illustration 5: Experimental HIFU ablation (fresh porcine ham).
Thus, we were quite optimistic of achieving complete ablation when applying a standard
ablation protocol using factory adjustment. In principle, this standard ablation protocol aimed
to achieve complete tissue distraction in the target area without injury to neighbouring
anatomical structures. However, this protocol was primarily developed for the treatment of
uterine fibroids.119 The applied HIFU system was approved by the European Medicines
Agency and the US Food and Drug Administration exactly for this application.
Anaesthesia protocol, animal procedural handling
For experimental studies on the swine model we applied an anaesthesia protocol, which was
previously developed in our centre, as a basis.120 Respiration stops in the position of maximal
expiration were necessary to enable HIFU planning, treatment and monitoring. The maximal
expiration position may have 2 benefits: it provides some oxygen in the lungs for gas
exchange in the early stages of respiration cessation, and it also results in caudal liver
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displacement, providing lesser coverage of the liver by the ribs. Consequently, a greater liver
volume becomes available for safe ablation.
Seven swine were used in non-survival acute experiments and the remaining six animals for
the survival experiments. Animals were anaesthetised with Pentobarbital, Isofluran and
Morphine.120 Tracheotomy was applied for the acute series, whereas survival pigs were
intubated. A Hickmann catheter was placed in vena jugularis externa in the survival series in
order to draw blood samples in the post-procedural period. The skin in the actual region was
carefully shaved to facilitate the propagation of ultrasound waves. Animals were transferred
to the MR room and placed in prone position with their liver facing the HIFU transducer.
Respiration was stopped in expiration for 1-2 min during the MR scanning and HIFU-
sonication. Prior to the respiration pauses, the swine were hyperventilated to guarantee
adequate oxygenation during respiration pauses.
Animals in the acute series were immediately euthanised after MR post-procedural imaging.
The whole liver and abdominal skin samples were resected for histopathology analysis.
Swine in the survival series were awakened and kept alive for a week. After follow-up MRI
examination, they were euthanised and their liver/skin samples were resected for
histopathological analysis.
Illustration 6: The experimental animal under treatment: A. An anaesthetised swine on the
HIFU-treatment table; B. Pig in the MR scanner under treatment.
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HIFU protocol
The duration of sonication was 30 to 48s, at a frequency of 1.2 MHz, and with an acoustic
power of 120-350 W. The HIFU focal point was automatically adjusted electronically to form
an ellipsoid cell of 4x3x10, 8x8x20 or 12x12x30 mm3, performed individually or in clusters
of overlapping cells.121 The standard sonication protocol implies a test low-energy sonication
prior to treatment sonication, which enables the power which is necessary for complete
ablation to be calculated based on the temperature rise.
Calculated HIFU-machine suggested power = Required temperature rise X Power X  Multiplication
Observed temperature rise factor
Multiplication factor was considered to vary from 1 to 2 depending on the type of treatment
cells and their size, but the recommendations from the manufacturer were not constant and
have been in continuous revision.
The sonication protocol was designed to investigate various characteristics, such as the use of
treatment cells with feedback, acoustic power level, multiple sonication cycles (at a single
location), and sonication cell agglomeration to clusters. Moreover, some ablations were
planned to include blood vessels in order to evaluate their cooling effect on HIFU sonication.
In order to avoid ablation of the major biliary ducts, MR-cholangiography was acquired
before sonication. In cases of multiple sonication cycles, the cooling time between single
sonications was needed to allow the abdominal wall temperature to decrease after sonication,
as well as to re-oxygenate the animal between each breath-hold.
Histopathology
After fixation, the liver was serially sliced to map thermal lesions. Samples were formalin-
fixed and paraffin-embedded before examination by light microscopy. Analysis was
performed after haematoxylin-eosin staining in a blind fashion by the pathologist in order to
describe the characteristics of the thermal lesions: localisation, size, shape, degree of tissue
injury. The analysis of samples from the anterior abdominal wall was also performed in cases
of injury suspicion.
Size measurements of ablation zones
Thermal dose contours were given in cross-sectional images at the focus location and in one
longitudinal image. Ablation size assessment from MRI was done from T1-weighed images,
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also including an intermediate zone when this was observed, immediately after HIFU
procedure and after one week for animals included in the survival protocol. As for
histopathology, two cross-sectional values were measured in addition to the ablation zone
length. Cross-sectional and length differences of ablation zones between target, calculated
thermal dose, post-procedural MRI, one-week control MRI and histopathology were
calculated as follows for all single cell sonication procedures: target minus histopathology,
thermal dose minus histopathology, and post-procedural MRI minus one-week control MRI.
Non-parametric statistical data analysis was used.
Post-procedural animal care and control
Intermittent intramuscular Buphrenorphine was administrated as analgesia during the first
three postoperative days and the animals were allowed free access to food and water. Body
temperature and blood samples were collected on a daily basis during that period. Blood
samples were analysed for general (haemoglobin, white blood cells with differentiation, C-
reactive protein, creatinine), liver-specific (bilirubin, alaninaminotransferasa,
aspartatamaminotransferasa, gammaglutamintransferasa, international normalised ratio) and
immunologic (interleukin, interleukin 1b, interleukin 6, interleukin 8, tumour necrosis factor)
tests.
7.4 Statistics
Statistical analyses were carried out using SPSS software. The main data are given as median
(range or 95% confidential interval) or number (percentage) and presented in accordance with
the intent-to-treat concept. The Kaplan-Meier method and the life tables were applied for
survival analyses. For the analysis of continuous variables, the Mann-Whitney U test was
used. For comparison of frequencies, the chi-square or the Fisher exact test was performed, as
appropriate. For survival comparisons, the log-rank test was applied.
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8 SUMMARIES OF PAPERS
Paper I: Laparoscopic liver resection for malignant and benign lesions: 10 year
Norwegian single centre experience48
During 1998-2008, Rikshospitalet accumulated a considerable experience in laparoscopic
liver surgery: 139 patients, 176 resections in 149 procedures (Figure 2, Paper 1). In 2000, we
established the database which has been prospectively updated. There were 113 patients with
malignant lesions, including 106 patients with metastatic tumours (96 colorectal metastases
and 6 carcinoids) and 7 with primary liver tumours (5 hepatocellular carcinoma, 2
cholangiocarcinoma) (Table 1, Paper 1). There were 27 patients with benign liver lesions
including 7 liver cysts, 6 haemangiomas, and 5 focal nodular hyperplasia.
Analysis of these data revealed good surgical and oncologic outcomes of laparoscopic liver
resection. The rate of conversion to laparotomy was 3.4%, and the median operative time and
blood loss were 164 minutes and 350 ml, respectively (Table 4, Paper 1). There were levels of
6.7% intraoperative and 12.6% postoperative complications. Postoperative mortality was
0.7% (one patient). The median postoperative stay and opoid requirement were 3 days and 1
day, respectively. Tumour-free resection margins (visualised by histopathology) were
achieved in 94% malignant specimens. There were small but significant differences in
operative time and blood loss between procedure for benign and malignant liver lesions.
This study showed that in current days with the application of advanced laparoscopic
equipment, anatomic resections do not provide better surgical or oncologic outcomes (Table
5, Paper 1). Therefore, the concept of preference of parenchyma-sparing non-anatomic, if
necessary multiple, liver resections has received strong support.
This paper has also emphasised the importance of proper teaching, issues of the generation
gap in surgery and the impact of healthcare management on all levels in the promotion of the
development and the wider application of this patient-friendly treatment around the world.122-
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We concluded that, in experienced hands, laparoscopic liver resection is a favourable
alternative to open resection. Perioperative morbidity and mortality, and survival following
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the laparoscopic resection of colorectal metastases, seem comparable to that of open
resections.
Apropos, we would like to cite the words of Prof. Michel Gagner, a recognised pioneer of
advanced laparoscopy and laparoscopic liver surgery, published in the Archives of Surgery as
a commentary to this manuscript: “The myth of increased venous gas emboli from
laparoscopy is shattered.”125
Paper II: Laparoscopic resection of colorectal liver metastases: Surgical and long-term
oncologic outcome117
One hundred patients undergoing surgery in 118 procedures between August 1998 and June
2009 at Rikshospitalet were included. Survival predicted by Fong’s and Basingstoke
Predictive Index (BPI) scores were taken as reference values for observed survival.126,127
The patients had median Fong’s and BPI’s scores of 2 (0-5) and 7 (0-23), respectively (Table
1, Paper 2). Mainstream analysis of hospital data was done on an intent-to-treat basis.
Intraoperative incidents and postoperative complications were analysed according to the
Satava and Clavien-Dindo classifications, with their adoption enabling application to
laparoscopic liver surgery. Median follow up was 24 (0-100) months.
One hundred and seventeen non-anatomic and 34 anatomic liver resections were performed
(Table 4, Paper 2). The median operative time and blood loss was 192 min and 300 ml,
respectively (Table 5, Paper 2). Intraoperative incidents occurred in 14 cases (11.9%)
including 5 (4.2%), 8 (6.8%) and 1 (0.8%) cases of grade I, II and III, respectively (Table 6,
Paper 2). Postoperative complications were observed in 16 cases (14.3%) including 2, 3, 7, 3,
0 and 1 cases of Grade I, II, IIIa, IIIb, IV and V, respectively (Table 7, Paper 2).
At follow-up, 32 (29.9%) patients were dead, 19 (16.2%) were alive with uncured disease
recurrence, and 56 (52.3%) patients were alive and disease-free. The latter group of patients
included 14 (13.1%) patients who were cured for metastatic recurrence.
Hepatic recurrence occurred in 45 (42.1%) patients after a median of 7.5 (2-47) months.
During follow-up, 21 repeated liver resections were performed, including 12 by laparoscopy
and 9 by laparotomy (Figure 1, Paper 2). Additionally, radiofrequency and cryoablations were
performed in 9 and 1 cases, respectively. Pulmonary metastases developed in 29 (27.1%)
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patients in median of 9 (2-56) months after the procedure and 14 lung resections of colorectal
metastases were performed, including 2 cases via thoracoscopy. No port site-metastases were
registered. Local recurrence of primary colorectal cancer was registered and resected in 3
(2.8%) patients.
The 5 year overall survivals were 51% as laparoscopically-completed cases and 47% as
intent-to-treat (Figure 2, Paper 2). The observed actuarial survival values exceeded the values
expected by Fong’s and the BPI score with 10.2% and 6.7% as laparoscopically-completed
cases and with 3.8% and 2.4% as intent-to-treat, respectively (Table 8, Paper 2).
In our series, the discordance between intent-to-treat and per protocol outcomes
(laparoscopically-completed cases) was statistically insignificant, i.e. “the intent was reached”
(Table 5, Paper 2). This indicates that one can consider the laparoscopic technique as a well-
established reliable method in the surgical treatment of colorectal liver metastases.
Laparoscopic resection appeared as a favourable alternative to open resection, as it is
associated with low morbidity and mortality and a beneficial postoperative course.
Oncologic outcome, including long-term survival, is comparable to or better than that of open
surgery; the observed actuarial survival is better than expected by Fong’s BPI scoring
systems. Laparoscopic repeated resections with the parenchyma-sparing technique play an
important role in this improvement.
The study has also enabled the development of the following general conclusions: 1) the
development and popularisation of a universal classification system of surgical complications
amenable to both open and laparoscopic surgery is an urgent issue; 2) reporting of both intent-
to-treat and per protocol outcomes should become a routine principle applied in the research
of new surgical modalities, as this principle gives a comprehensive outcome picture for a
reader, reduces bias in outcome presentation and enables the reliability of new surgical
techniques to be measured; and 3) a new distinguished definition of disease-free and
recurrence-free survival is warranted and should receive wide acceptance in the surgical
society, as this definition more precisely corresponds to the current development of surgical
oncology.
Paper III: Is Laparoscopic Repeat Hepatectomy Feasible? A Tri-institutional
Analysis128
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Laparoscopic liver resection has become a viable alternative to open hepatectomy. Multiple
centres throughout the world have reported laparoscopic-assisted or totally laparoscopic liver
resections including major hepatectomies.129 With increasing data showing improved survival
following repeat hepatic resection for recurrent colorectal liver metastases, demand for repeat
hepatic resections is increasing.78,130,131
Despite recent advances in operative technology and the field of liver surgery, repeat hepatic
resections are traditionally performed in an open fashion. Complexity of liver anatomy and
challenges of repeat operation have prohibited the adoption of laparoscopic techniques for
repeat hepatic resections among hepatobiliary surgeons. Our institution collaborated with two
other pioneer centres in laparoscopic liver surgery, one French centre (group of Prof. Brice
Gayet) and one American (group of Prof. Joseph Buell).
We intended to evaluate safety, feasibility, oncological integrity, and outcomes of
laparoscopic repeated liver resections, and to outline the selection criteria for this approach.
An intent-to-treat analysis was performed. From 1997 to 2009, 76 laparoscopic repeated liver
resections have been attempted. Operative indications were metastasis (63), hepatocellular
carcinoma (3), and benign tumours (10). All patients had one or more prior liver resections
(28 open, 44 laparoscopic), including 16 major resections (en-bloc removal of 3 or more
Couinidad segments) (Table 2, Paper 3).
Eight cases were converted (11%) to open resections (7) or radiofrequency ablation (1) due to
technical difficulties or haemorrhage. Laparoscopic repeated liver resections included 49
wedge or segmental and 19 major hepatectomies (Table 4, Paper 3). Median blood loss and
operative time were 300 ml and 180 min (Table 3, Paper 3). Patients with prior open liver
resection experienced more intraoperative blood loss and transfusion requirements than those
with prior laparoscopic resections (p= 0.02, p= 0.01). R0 resection was achieved in 58 (92%)
patients with malignant tumours. The incidence of postoperative complications and duration
of hospital stay were not statistically different between patients primarily operated upon via
either laparoscopy or laparotomy. Major complications occurred in 6 (8%) cases (Table 6,
Paper 3). There were no perioperative deaths. Median tumour size and number was 25 (5-125)
mm and 2 (1-7), respectively. Median follow-up was 23.5 (0-86) months. There was no port-
site metastasis. The 3-year and 5-year actuarial survival for patients with colorectal metastases
were 83% and 55%, respectively (Figure 3, Paper 3).
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We concluded that laparoscopic repeat liver resection was feasible, safe, and oncologically
adequate. The short-term results were comparable with laparoscopic primary liver resections,
and are superior to repeat liver resections performed in an open fashion. In patients with
colorectal metastasis, intermediate and long-term oncologic results appear to be similar to the
best series reported for open counterparts. Due to less operative blood loss and a lower
requirement for blood transfusions, the best candidates for laparoscopic repeat resections are
those with prior laparoscopic resections.
Paper IV: Comparative evaluation of laparoscopic liver resection for posterosuperior
and anterolateral segments82
Despite tremendous advancements in the field of laparoscopic hepatobiliary surgery related to
both operative techniques and instrumentation, most laparoscopic liver resections still are
mainly performed for easily accessible lesions.80 Totally laparoscopic liver resection of
lesions located in the posterosuperior segments is reported to be technically challenging.132
This study aimed to define whether these technical difficulties affect the clinical outcome.
A total of 220 patients underwent laparoscopic liver resection during 244 procedures from
August 1998 to December 2010. The patients who underwent primary minor single liver
resection for malignant tumours affecting either posterosuperior segments 1, 7, 8, and 4a
(group 1) or anterolateral segments 2, 3, 5, 6 and 4b (group 2) were included in the study
(Figure 1, Paper 4). Seventy-five procedures were found to be eligible for the study, including
28 patients in group 1 and 47 patients in group 2. The majority of liver tumours in both groups
were colorectal metastases. Intraoperative unfavourable incidents were graded on the basis of
the Satava approach and postoperative complications were graded in agreement with the
Accordion classification (Clavien-Dindo-Strasberg classification).
To reach the most problematic segments (7 and 8), four laparoscopic port sites were usually
required. The patient’s right abdominal side was elevated up to between 45° and 60°. Usually,
12-mm port sites were used to enable the application of a wide range of laparoscopic
instruments and devices. Patient positioning and trocar placement should be carefully adjusted
according to the tumour location and patient constitution (Figure 2, Paper 4).
No conversions to open surgery occurred in either of the studied groups. The operative time
(median, 127 min) and blood loss (median, 200 ml) were equivalent in the two groups (Table
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5, Paper 4). The rates for blood transfusions and intraoperative accidents did not differ
statistically between the groups. The median tumour size was similar in the two groups. No
significant difference in weight or dimensions of the resected liver specimen was observed. A
tumour-free margin resection was achieved in 94.7% of the procedures, and was equivalent in
both groups (Table 6, Paper 4). The postoperative course was similar in the two groups.
Postoperative complications developed in 2 cases (7.1%) in group 1 and 2 cases (4.3%) in
group 2 (p = 0.626). The median hospital stay was 2 days in both groups.
The study verified that laparoscopic liver resection for lesions located in the posterosuperior
segments represents certain technical challenges. However, we have proven that the
appropriate adjustment of surgical techniques and optimal patient positioning enables the
laparoscopic technique to provide safe and effective parenchyma-sparing resections for
lesions located in both the posterosuperior and anterolateral segments.
Paper V: Acute and survival studies of extracorporeal magnet resonance guided high
intensity focused ultrasound ablation in the swine liver133
Among the different options for liver ablation radiofrequency, laser and cryoablation are currently
the most popular methods. 134 135 136 However, these methods are still associated with a high risk
of tumour recurrence. HIFU is a recently introduced modality for liver ablation with fast-growing
popularity.98,137,138 HIFU ablation can be performed non-invasively, the site and shape of the
lesion can be chosen and lesions are precisely defined;109 it can also potentially be performed
without general anaesthesia and without any risk of tumour seeding due to needle tracks.110,111
An experimental study on the porcine model was designed to develop extracorporeal MR-
guided HIFU ablation of the liver for its further application in patients.
Thirteen Norwegian land swine were used for the development of extracorporeal HIFU
ablation of the liver in the porcine model monitored by MRI. The thermal ablation
experiments were performed with a Sonalleve MR-HIFU platform (Philips Healthcare,
Vantaa, Finland), integrated to the bed of a 3T MR scanner (Achieva, Philips).
Seven animals were used for the development of ablation protocol in the non-survival acute
experiment and the remaining 6 animals for the optimisation of the ablation protocol in the
survival experiment.
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All swine were anaesthetised with Pentobarbital, Isofluran and Morphine.120 Tracheotomy
was applied for the acute series, whereas survival pigs were intubated. A Hickmann catheter
was placed in the vena jugularis externa in the survival series in order to draw blood samples
in the postprocedural period. The skin in the actual region was carefully shaved to facilitate
the propagation of ultrasound waves. Animals were transferred to the MR room and placed in
prone position with their liver facing the HIFU transducer. Respiration was stopped in
expiration for 1-2 min during the MR scanning and HIFU-sonication. Prior to the respiration
pauses, the swine were hyperventilated to guarantee adequate oxygenation during respiration
pauses. Animals in the acute series were immediately euthanised after MR post-procedural
imaging. The whole liver and abdominal skin sample (if suspected thermal damage) were
resected for histopathology analysis. Swine in the survival series were awakened and kept
alive for an average of 8 days (range 7-9). After follow-up MRI examination, they were
euthanised and their liver/skin samples were resected for histopathology analysis.
The anaesthetic protocol was successful in all cases; pCO2 was recovered within 2-3 minutes
of hyperventilation. The median total procedure time was 380 (265-640) min (Table 1, Paper
5). There was no statistical difference between target and histology cross-section
measurements (Table 2, Paper 5). This was true in regard to the ablation length as well in the
absence of MR registration of heat sink. When heat sink was observed, ablation length
appeared to be reduced compared with the target value.
Thermal dose calculation shows no or little differences compared to histopathology
measurements for normal heating and heat sink respectively. There was no statistically
significant difference between ablation size determined by post-procedural MRI and
histopathology, both for normal heating and heat sink, respectively. There was no difference
in ablation size between post-procedural MRI and one-week control MRI measurements in the
survival series.
The ordinary sonication protocol, which is primarily elaborated for uterine fibroid ablations
(maximal acoustic power of 200 W, sonication duration up to 67.4 s), resulted in reversible
alterations of the liver parenchyma (mostly bleeding) (Figure 3B, Paper 5). Application of
ablations with a multi-cycle sonication protocol provided liver parenchyma ablation
confirmed by radiological examination, with no gadolinium contrast uptake in the ablation
zones. However, histopathology structural observations showed only partial coagulative
necrosis (Figure 5, Paper 5). The application of high energy ablations (300-350 W, sonication
duration 20.5 s) together with a multi-cycle protocol has provided complete coagulative
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necrosis liver tissue, as confirmed by structural histopathologic observation (Figure 6, Paper
5). Tissue vaporisation and cavitation occurred at this acoustic power level and the
hyperthermia regime was different than at ablation created with 200W acoustic power. This
regime resulted in a larger ablation volume than planned due to the observed cavitation.
Histopathology was more marked in the periphery of the ablation rather than in the centre,
forming two ablation zones – central and peripheral – in this way (Figure 3, Paper 5).
Non-intended injuries were recorded in 3 out of 9 animal cases that underwent HIFU
treatment. They were presented as burn injuries of the abdominal wall in swine with the multi-
cycle low energy protocols (within 200 W). Potential near field heating was detected using
MR thermometry in all of these cases. These unintended injuries were associated with long
cumulative sonication time.
We concluded that extracorporeal HIFU ablation of the liver under 3 Tesla MR guidance is
feasible but challenging due to the high vascularity of liver parenchyma. However, the
optimal acoustic power for successful ablation remains to be determined. The impact of multi-
cycle protocol, issues of functional analysis of irreversible tissue damage and power-
dependant threshold to cavitation onset require further studies in order to enable the safe
application of this technique for liver ablation in a clinical setting.
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9. DISCUSSION
9.1 Laparoscopic liver resection for benign and malignant liver lesions
Laparoscopic liver resection was associated with low morbidity in our series. Intraoperative
incidents and postoperative complications developed in 6.7% and 12.6%, respectively. 30-day
mortality was comparable to that of open surgery (below 1%).
Bleeding and biliary leakage are related to surgical experience and skills, although the
availability of high-tech surgical equipment has reduced these problems.139 In addition,
tumour location and size are associated with complication hazards. The low rate of
postoperative infections observed with the laparoscopic technique may be an important gain
in prevention of post-resection liver failure.140
Quite similar surgical results of liver resection for benign and malignant liver lesions were
demonstrated in our series, although the latter group of patients had worse physical statuses
and a higher rate of previous laparotomy and liver resection (Table 4, Paper 1).
Laparoscopic liver surgery was introduced in 1992, but this technique has not yet been
generally accepted.27,39,42,43,45,46,49-53,141-144 The development of surgery has been faster than
the evolution of the hospital and university administration.87 Most hepatobiliary centres
perform barely-open hepatectomies. Open procedures still dominate, even in the majority of
centres performing laparoscopic hepatectomies.  Technical aspects of liver resection are still a
matter of debate, even if the major challenges have been resolved and accepted; it remains
time-consuming and difficult to attain mastery in laparoscopic hepatectomy. Many
“traditional” surgeons promptly learned simple laparoscopic procedures, but find it rather
demanding to learn more technically advanced procedures. Owing to the high specialisation
within the units performing liver surgery, simple cases for laparoscopic training are not easily
available. This is the main reason for the lack of fundamental laparoscopic skills among the
senior generation of consultant surgeons in specialised hepatobiliary centres, which again
holds back the rapid development of laparoscopic liver surgery in general as well as in
individual centres.
The concept of segment-orientated anatomic hepatectomy has made an important contribution
to the recent development of liver surgery.145 Anatomic resections have been demonstrated to
be associated with better haemostasis and the control of bile leakage as compared to non-
anatomic resections.146 On the other hand, new surgical technologies of ultrasound and
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coagulation-based parenchyma transection have reduced the benefits of anatomic resection.147
A fairly increased operative time for anatomic resections was the only difference observed
between anatomic and non-anatomic techniques in our series (Table 5, Paper 1).
Formal hemihepatectomies represent special concerns and are coupled with significantly
increased technical challenges. Subsequently, this leads to a more time-consuming operation.
In the early period, we mainly carried out minor resections, but, after having accumulated
experience, we started to accept all groups of patients considered in conformity with classical
rules of open liver surgery. Despite the intraoperative technical challenges of major
resections, the laparoscopic method still results in an improved postoperative course, as also
shown by others.46 A recent multicentre study including 210 patients reported good clinical
outcomes of laparoscopic hemihepatectomies with a mortality below 1%.148
Good skills in advanced laparoscopic surgery and liver surgery are essential. Surgical
transection equipment could be improved. Prospective bilateral interactions between surgeons
and industrial engineers is therefore of high importance.149
In spite of the routine use of 12 mm trocars, we did not place sutures on the fascia in case of
the application of the radially-dilating trocar system. Nonetheless, we did not examine any
cases of trocar hernia in our series; therefore, we can state that with the radially-expanding
troacar system, there is no need to routinely suture the fascial layer if trocars up to 12 mm are
utilised.
Learning is a crucial point of liver resection.150 The availability of several high-resolution
large size monitors in the operating room allows surgeons to examine not only intraoperative
ultrasonography but also preoperative imaging, including three-dimensional reconstruction of
vessels and bile ducts. This may further facilitate intraoperative navigation and contribute to
learning by enabling interactive intraoperative discussion between experts and fellow
surgeons to adjust surgical tactics based on the analysis of pre- and intraoperative imaging and
current procedural circumstances.151-153
One cannot anticipate the prompt and uncomplicated introduction of laparoscopic liver
surgery without the support of healthcare management.154 Fellow surgeons should be
encouraged to attend expert centres to learn “how to do it”. Experts have an ethical duty to
share their knowledge with local and guest fellow surgeons and to visit other centres to
perform demonstrative pilot cases. Educational training programs organised by professional
societies should also be encouraged. Nevertheless, without a collaborative atmosphere in
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departments of hepatobiliary surgery and the individual surgeon’s fervour it would be difficult
to thrive in this complicated field of surgery.
9.2 Laparoscopic liver resection for colorectal liver metastases
Our studies demonstrated that laparoscopic liver resection could be safely applied in regard to
colorectal metastases in the liver by an experienced team. The operation has low morbidity
and postoperative mortality and good short- and long-term oncologic results.
It has been reasoned that intent-to-treat analysis is advantageous over per protocol analysis.155
Besides, a discordance between intent-to-treat and per protocol analysis may play a role as a
reliable measuring tool of a well established new treatment modality.156 In our series, the
discordance between intent-to-treat and per protocol outcomes (laparoscopically-completed
cases) was very small and statistically insignificant, i.e. “the intent was accomplished”. This
suggests that the laparoscopic technique can be deemed as a well-established reliable method
in the surgical treatment of colorectal metastases in the liver. Reporting of both intent-to-treat
and per protocol outcome computations are presently uncommon in surgical science;
however, this principle gives a comprehensive outcome picture for a reader, decreases a bias
in outcome presentation and allows the reliability of a new surgical method to be measured.
Thus, we advocate this principle to be routinely applied in the research of new surgical
techniques in regard to both prospective and retrospective studies.
Patient selection for surgery is challenging, but it is a prerequisite of good treatment results. In
an attempt to systematise the patient selection, several scoring methods have been elaborated.
However, they have limited clinical value for patients with metastatic colorectal cancer.157
Over the last decades, improvement in surgical and oncological outcome following resection
of colorectal liver metastases has been observed. This progress has endorsed the
implementation of wider indications for hepatectomy. A multimodal approach implying
repeated liver resections, ablative modalities and chemotherapeutic down-staging has allowed
the treatment of patients who were not previously candidates for surgery. 158
Fine needle aspiration biopsy of liver lesions has been reported to cause tumour dissemination
and adversely affect survival; also, perfection in preoperative tumour staging due to advanced
imaging and interventional techniques has made needle biopsy of liver lesions futile.159
Consequently, in our series, preoperative biopsy was used in a few cases only and mainly in
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an earlier period. Laparoscopic exploration is a preferable initiation of surgical
intervention.160 If there is preoperatively unrecognised inoperability, the surgeon can avoid
unnecessary laparotomy, and in the case of a resectable tumour, the surgical team can choose
between a laparoscopic or open approach.
Increased operative time and a tendency to a higher rate of intraoperative unfavourable
incidents were registered in patients undergoing long-lasting neoadjuvant chemotherapy, as
reported by others.161 However, this has not worsened the postoperative course and rate of
postoperative complications.
The postoperative course was equal whether the intent-to-treat or per protocol analysis was
applied: the median duration of postoperative stay was just 3 days (2 days in present); the vast
majority of patients started to consume fluids on the day of operation and almost all patients
started to consume solid food on the first postoperative day.
The five year overall actuarial survival after laparoscopic liver resection was 51% in
laparoscopically-completed cases and 47% in intent-to-treat in the series of colorectal liver
metastases. These values correspond to the best reported outcomes after open liver resection
and are better than outcomes from our own earlier reported experience with open surgery
(29%).162-164 The possible contribution of laparoscopic techniques to this improvement may be
explained by a decreased impairment of the immune system due to less traumatic
intervention165,166; nevertheless, this hypothesis should be further studied. However, the
results of open surgery have improved during the last decade as well,167 therefore our
outcomes after open liver resection need to be re-evaluated.
Laparoscopic approach facilitates repeated parenchyma-sparing resections due to minimal
adhesion formation and the operation is also better tolerated by patients. Parenchyma-sparing
liver resection should thus be carried out whenever possible.28 Some studies advocated that
anatomic resections could potentially provide better oncological outcomes,168,169 but this
hypothesis has been shown to be unclear.170,171 Our series designate equal survival and liver
recurrence rate after anatomic and non-anatomic liver resections of colorectal metastases. The
parenchyma-sparing concept increases the possibilities for repeated resections and the
probability to maintain sufficient liver functional reserve thereafter.172,173 In this context, it
could extend patient life.
Our patients had quite advanced disease. About half of our patients had synchronous
metastases and more than two third had primary tumour Dukes stages C and D. Both the Fong
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score and the BPI score have been applied for patient evaluation. The BPI score looked to be
more precise with regard to survival prediction. We have recorded a better observed actuarial
survival than could be expected from the Fong and the BPI scores (2.6-10% and 0.3-6.7%,
respectively) (Table 8, Paper 2). One can attribute this improved survival to the contribution
of the laparoscopic technique; however, such a hypothesis should be further studied in
prospective randomised studies. Both the Fong and the BPI scoring systems have been
developed based on the analysis of patients operated upon via the open approach.
Tumour recurrences happened in the liver in 45 patients and in the lungs in 29 patients (Figure
1, Paper 2). No port-site metastases were registered, which could be attributed to a meticulous
maintenance of developed routines to minimise the risk of port-side metastases.174 Many of
the hepatic and pulmonary recurrences were treated by surgical radically-considered
resections. This resulted in the fact that, despite a low five-year recurrence-free survival rate
of 24%, the five-year disease-free survival was 42%, approaching the five-year overall
survival of 51% (Figure 2, Paper 2).
It may even be reasonable to attempt resection of extrahepatic disease in selected patients. It is
crucial to note in this regard that the classical definition of cancer-related survival after
surgery does not distinguish between recurrence-free survival and disease-free survival
(disease-free survival typically corresponds to recurrence-free survival in our definition). The
concept of distinguishing between recurrence-free and disease-free survival is not new and it
was earlier accidentally used in surgical oncology.175 However, multiple and repeated
interventions and parenchyma-sparing techniques in patients with metastatic colorectal
disease have been discussed and performed over the last decade. It is thus necessary to
distinguish between the terms ”recurrence-free” and ”disease-free survival” in order to justify
the new approach and to obtain more precise documentation of oncologic results.
Hepatectomy for colorectal metastases has changed from a single surgical attempt to a multi-
modal treatment approach of recurrent metastatic disease including surgery, local ablation,
chemotherapy and parenchyma-increasing techniques such as portal vein embolisation.
Therefore, multimodal treatment has transformed the disease from a rapidly deadly disease to
a more chronic condition.
9.3 Laparoscopic repeat liver resections
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Repeat hepatectomies have been reported by several centres, but they are actually performed
infrequently. The usual indication for recurrent hepatic resection is local recurrence of
colorectal liver metastasis.12-15. Repeat hepatectomy is quite a challenging procedure.
A key point of this study was the extensive experience of all participating institutions in
laparoscopic liver surgery (our centre; Department of Digestive Diseases, Institut Mutualiste
Montsouris – the group of Prof. Brice Gayet, Paris, France; Departments of Surgery,
University of Louisville, the group of Prof. Joseph Buell, Louisville, USA). The rate of
postoperative complication (32%) and bile leakage rate in particular following repeat
laparoscopic liver resection (6.6%) corresponds to the rate previously reported for
laparoscopic primary liver resections (Table 7, Paper 3).5,7,9,10,22 Zero mortality and an
acceptable conversion rate (11%) underlines the laparoscopic technique as a viable option to
the open counterpart for the management of recurrent disease (Table 8, Paper 3).
Intraoperative haemorrhage and transfusion requirements in this series were quite similar to
those reported for primary laparoscopic hepatectomies. When comparing the group of prior
laparoscopic liver resection with the group of prior open liver resection, reoperation after a
previous laparoscopic procedure was associated with a lower bleeding and transfusion
requirement (Table 3, Paper 3). These data may be construed by increased adhesions after an
open liver resection, requiring wide adhesiolysis. After loosening of abdominal adhesions
with the identification of normal anatomical landmarks, both groups underwent identical
operations with similar postoperative course.
Although laparoscopic repeat liver resection following open hepatectomy is associated with
higher blood loss and transfusion requirements, the surgical outcomes are acceptable when
compared to laparoscopic primary liver resection series (Table 6, Paper 3).
Multiple series of open repeat liver resections for colorectal metastasis showed higher intra-
operative haemorrhage with longer durations of hospital stay for open repeat liver resection
versus the laparoscopic repeat liver resection group (Table 8, Paper 3). This observation
persisted even in the subgroup analysis of patients with prior open liver resection undergoing
laparoscopic repeat liver resection.
The laparoscopic technique is preferable for repeat liver resections in our group, regardless of
the approach for primary liver resection. The criteria for the application of laparoscopic
approaches for laparoscopic repeat liver resection were the same as for laparoscopic primary
liver resection. The necessity of biliary or vascular reconstruction was deemed the only
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ultimate contra-indication to laparoscopic repeat liver resection. The surgeon performing
laparoscopic repeat liver resection should have sufficient experience and should have
mastered the corresponding primary laparoscopic liver resection.
Intraoperative ultrasound presents a crucial tool to perform repeat hepatectomy as the number
of lesions found intraoperatively was underestimated in 12%, and overestimated in 8% of the
cases in our series. Scrupulous ultrasound examination resulted in a high rate of R0 liver
resections (92%). One area of concern in this and other series has been a diminished resection
margin. In the present series, the pathologic margin was less than 1 mm in 8%. Apparently,
laparoscopic liver resection often utilises various methods of surgical technology, including
staples. These technical tools may artificially lessen the surgical margin, as anatomical
fixation does. In spite of this confusing fact, our results are parallel to those reported for
laparoscopic primary liver resection and open repeat liver resection. In our experience, the
location of the tumour in proximity to important vascular structures and the potential size of
the liver remnants are critical factors in dictating the magnitude of resection margins.
Our series presents the first large series of laparoscopic repeat hepatic resections reported in
the literature with equivalent safety, efficacy and oncologic integrity to other reported open
resection series and primary laparoscopic resection series.
9.4 Laparoscopic liver resection for lesions located in laparoscopically difficult accessible
and challenging segments
This thesis demonstrated that laparoscopic liver resection can be performed safely for lesions
located in both the anterolateral and posterosuperior segments by an experienced surgical
team. The low rate of perioperative adverse events (5.3% of both intraoperative unfavourable
accidents and postoperative complications) and zero conversion and mortality were observed
in the analysed groups.
However, operations for lesions located in posterosuperior segments (so-called “difficult
segments”) are mostly reserved for open surgery, even in centres widely performing
laparoscopic hepatectomy.
For tumours located in segment VII or segment VIII, non-anatomic liver resection or right
posterior sectionectomy are preferable to right hemihepatectomy, as this preserves the liver
parenchyma. However, these procedures are technically more challenging. Although only a
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small volume of liver parenchyma is usually removed in non-anatomic liver resection, these
resections in segments VII-VIII are technically difficult, because the exposure of deeply
located lesions is intricate and the transection plane can be rounded or angled.53,176,177
Hanging techniques, implying mobilisation of the right liver lobe and dissection along the
caval vein and up between the orifice of the right and the middle hepatic veins, enabling to
hang on the right liver lobe, could be of major help.
In our series, the laparoscopic approach to posterosuperior segments was not related to
major difficulties or increased morbidity; this observation has been supported by equal both
intraoperative and postoperative outcomes of resections of the anterolateral and
posterosuperior liver segments. Proper adjustment of trocar placement, the use of a flexible
laparoscope, wide mobilisation of the right liver lobe and adequate use of gravity are of major
help in such cases (Figure 2, Paper 4). We found that the availability of several high-
resolution large size monitors in the operating room, enabling surgeons to view not only
intraoperative ultrasound pictures but also preoperative imaging, including three-dimensional
reconstruction of crucial vascular and biliary structures, was of great help (Figure 3, Paper 4).
This further improves intraoperative navigation and may therefore play an important role in
laparoscopic liver surgery, particularly in the case of tumours located in posterosuperior
segments.152,178
The minimal distance from the resection line to tumour tissue was the only parameter which
differed significantly between the studied groups (Table 5, 6, Paper 4). In regard to malignant
liver lesions, we always aimed to attain resection with sufficiently safe resection margins,
irrespective of the tumour location. The observed phenomenon might occur because of poorer
exposure of the operative field during the approach to tumours located in posterosuperior
segments; this resulted to increased concerns with regard to possible vascular or biliary injury.
Consequently, the surgeon was able to cut closer to the tumour margin to prevent any
additional risk while retaining a secure free margin. In our series, this phenomenon did not
lead to a higher rate of tumour-involved resection margins, to a higher recurrence rate in the
liver or to a poorer survival in the group of patients with resections of lesions located in
posterosuperior segments.
Thoracoscopic access was suggested to approach segments VII and VIII.179 This access is
associated with longer operative time and opening of thoracic cavity, and may therefore result
in increased complication hazards.180,181 This indicates that the employment of thoracoscopic
access is not flawless. A recent publication from Japan stated that the authors had switched
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from a thoracoscopic to laparoscopic approach for the resection of lesions in segment VII due
to a lack of noticeable advantages.182
A completely laparoscopic approach was used in our series rather than the hand-assisted
approach utilised by many others.183,184 Our group believes that the hand-assisted method or
hybrid techniques have a limited role.176 These techniques supply a tactile sensation lacking
during laparoscopy; however, this approach requires a larger incision, which reduces the
benefits of minimally invasive surgery. Besides, fatigue in the inserted hand and air leakage
represent the drawbacks of the hand-assisted method.185 In addition, these techniques go
against the educational doctrine of bilateral development of operative skills of resident
surgeons; thus, these methods are considered to be lame regarding the educational perspective
for the development of young surgeons. However, a hand-port could be applied in very
challenging situations and tumour localisations when the surgeon does not achieve significant
progress in the procedure or feels himself not fully confident without tactile control of the
resection.
Intraoperative ultrasound could partially substitute the absent tactile sensation during the
totally laparoscopic approach; thus, its employment during laparoscopic hepatectomy is
mandatory to ensure adequate tumour identification and margin control.186,187
Adequate haemostatic control has been observed in both patient groups owing to the use of
modern surgical equipment.
9.5 High intensity focused ultrasound ablation of the liver
Acute experiment
Our results of early acute series have shown only bleeding in areas of ablation by structural
histopathology (Figure 3B, Paper 5). This urged us to find ways to adjust the protocol in order
to achieve infallible tissue distraction. As a first step, we continued to use normal cells for
treatment and not feedback cells. The feedback cells were developed to automatically stop
sonication by the machine, based on the calculation of redundant energy application revealed
by theoretical thermal dose reckoning.188 Experience with liver ablations has shown that the
HIFU machine stops sonication before sufficient temperature augmentation. This appears to
be due to different properties of the liver and the uterine tissues (reference tissue for automatic
machine adjustment of ablation characteristics), especially those related to vascularisation.
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In swine 2, we applied a multiplication factor 1-1.2, which resulted in a calculated power that
was in the region of 120-180 W. We concluded that this multiplication factor was not
sufficient. Only 5 out of the 7 processed HIFU ablations were confirmed in swine 2 by
histopathology (6 by MRI). Calculations based on multiplication factor 2 resulted in a
recommended power in the region of 200-300 W.
Histopathology confirmed only minor reversible alterations in swine 2, 3 and 6. Having these
quite dispiriting results and without any opportunity to increase an applied power over 200 W
(the HIFU machine had a program limitation for the applied power for patient security), we
considered multi-cycle ablation as a way to increase the alterations in the liver parenchyma
(swine 7). Nevertheless the alterations after introduction of the multi-cycle protocol were still
not sufficient enough to cause necrotic changes (in accordance with structural histopathology)
in acute experiments.
Survival study
The initiated survival series (swine 8-13) with multi-cycle ablations (3-5 cycles) have enabled
moderate histopathologic alterations presented by parenchymatous bleeding and partial
necrosis to be revealed. However, the rate of burn injuries to the abdominal wall substantially
increased. These more pronounced histopathologic alterations could be explained by the
sufficient survival interval enabling the development of registerable alterations. The increase
of the number of cycles to 24 in swine 11 caused severe and extensive alterations, but did not
cause complete necrosis. At the same time this almost doubled the total time of the procedure.
It became clear that with the application 200 W for ablation, even together with the multi-
cycle protocol, it is impossible to achieve complete necrosis (defined by structural
histopathology) of the targeted area in the liver parenchyma. In addition to the high power of
300-350 W, sonication time was also shortened to 20.5 s; this could promote both complete
coagulation necrosis due to the decreased time for temperature leak from the treatment area
and the prevention of burn injury in the abdominal wall. As a consequence, our experiment
finally resulted in coagulated necrosis, although we only used the 5 cycle protocol (Illustration
7). Tissue vaporisation and cavitation occurred at this acoustic power level and the
hyperthermia regime was different than the ablation created with 200W acoustic power. This
regime resulted in larger ablation volume than planned due to the observed cavitation.
There are various methods used to verify necrotic alterations of liver parenchyma.189 We
chose to use a conventional haematoxylin-eosin staining and reticuline staining in a few cases.
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Enzyme histochemistry (nicotinamide adenine dinucleotide phosphatediaphorase and succinic
dehydrogenase) have recently been used to verify tissue viability104,190; however, the value of
these methods is not well known. The structural histopathology analysis used showed
conflicting results, as coagulative necrosis was visually estimated between 5 and 10% in
ablated zones. This may also indicate that histological evaluation is limited for the
characterisation of heat-induced biological changes.191 Functional alterations in tissues were
reported to occur earlier than structural histopathologic changes after hyperthermia.192,193 This
discrepancy may indicate the need for more advanced characterisation methods in the
assessment of successful liver ablation in addition to classical visual histopathological
assessment with haematoxylin-eosin staining.194 A visual observation of ablations with
sonication and an acoustic power of 200W could support the presence of this discrepancy
(Illustration 8). The created lesions were stiff compared to normal liver parenchyma and they
were white-coloured i.e. their appearance resembled boiled tissue. In the mentioned case, MR-
based calculated thermal dose thermometry and MRI perfusion measurements indicated tissue
death in ablated regions, whereas histopathology examination with haematoxylin-eosin
staining does not support these findings. Further studies are required to examine the functional
tissue viability following mild HIFU hyperthermia.
Illustration 7: Microscopic picture showing complete coagulation necrosis
(magnification 100, haematoxylin-eosin staining).
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Illustration 8: Ablation lesion in the liver (swine 7): A. MR picture after liver ablation; B.
Visual appearance of this lesion immediately after liver extraction.
A. B.
Lessons
In fact, the abdominal wall was a more probable area for non-intended thermal injury than the
near field which could be concluded both from on-line temperature monitoring and from
radiologic post-sonication reports, including MR-cholangiography together with
histopathologic evaluation.
Although Gadolinium enhancement MRI of the liver was argued to be an excellent tool to control
after ablative treatment,195,196 our series has not shown the capacity of this technique to clearly
distinguish coagulative necrosis from minor haemorrhagic alterations. Further trials to define a
role of Gadolinium enhancement MRI in liver ablative therapy, and HIFU in particular, are
necessary.
Due to the small volume of the performed ablations it is impossible to make definitive
conclusions in regard to immunologic alteration and the release of liver enzymes into the
blood. However, liver enzyme levels normalised within 3-6 days which is similar to the
corresponding period for radiofrequency ablation in a clinical setting.197 We did not observe
increase in markers of immunological stress tests (interleukin, interleukin 1b, interleukin 6,
interleukin 8, and tumour necrosis factor) which is promising. Nevertheless, immunologic
consequences of ablative treatment required further studies.198
Two phenomena observed during ablation need special attention. First, the ablation also gets
the intermediate zone which bounds the ablative zone from the normal non-injured liver
parenchyma. In the acute series it is presented by sinusoidal congestion and in survival series
by multinucleated giant cells, proliferation of fibroblasts and small bile ducts, sinusoidal
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congestion is minimal. The ablation zone is fully presented by a homogenous zone of
coagulation necrosis in cases of high energy ablation. In cases of insufficient power, more
prominent alterations develop in the periphery of the ablation zone, creating central and
peripheral parts of the ablation zone (Illustration 9).
Another phenomenon was observed that needs further investigation. Small calibre vessels do
not considerably influence the shape of the ablation, whereas major vessels shear ablation
without any essential injury to the vessel integrity (Illustration 10). This phenomenon can be
very useful in patients with tumours sitting very close to the liver hilus who are not good
candidates for surgery.199
The application of high energy ablations (300-350 W, sonication duration 20.5 s) together
with the multi-cycle protocol has provided complete coagulative necrosis liver tissue, as
confirmed by structural histopathologic observation. The tissue vaporisation and cavitation
that occurred at this acoustic power level and hyperthermia regime was different to that at
ablation created with 200W acoustic power. This regime resulted in larger ablation volume than
planned due to the observed cavitation.
Extracorporeal HIFU ablation of the liver under 3 Tesla MR guidance is feasible but
challenging due to the high vascularity of liver parenchyma. Optimal acoustic power for
successful ablation remains to be determined. The impact of the multi-cycle protocol, issues
of functional analysis of irreversible tissue damage and power-dependent threshold to
cavitation onset require further studies in order to enable the safe application of this technique
in a clinical setting for liver ablation.
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Illustration 9: Ablation division to central and peripheral parts. The intermediate zone
bounds the ablative zone from the normal non-injured liver parenchyma.
A. Schematic drawing of typical HIFU ablation in the liver parenchyma made by application
of the Sonalleve MR-HIFU platform;
B. Post-procedural picture;
C. Macroscopic picture after fixation;
D. Microscopic picture (magnification 40, haematoxylin-eosin staining).
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Illustration 10: A. Vessel in the peripheral parts of the ablation zone which survived
ablation; B. Segmentation of the clustered ablation, which shows the irregular shape due to
multiple heat sinks from surrounding blood vessels.
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9.6 Future aspects
What is the future of interventions in the liver?
Can laparoscopic liver surgery largely substitute its open counterpart? We may quite
confidently say “yes”.
Can HIFU totally replace liver surgery? We may quite confident say “not in the near future”.
Consequently, the accumulated research, clinical and organisational experience has enabled us
to initiate two new projects in this field of medical research and practice:
1. Randomised trial of laparoscopic versus open liver resection for colorectal metastases.
2. High intensity focused ultrasound ablation of the liver under 3 Tesla magnet resonance
guidance: Refinement experimental study.
Study 1 will carry out evidence-based data on the following particular research issues:
A) Surgical stress and immunosuppression;
B) Economics;
C) Quality of life;
D) Long-term oncologic outcomes.
Study 2 will further develop MR-guided HIFU for liver lesions. The following points are to be
studied:
1. Is coagulative necrosis defined by classical histopathologic evaluation with haematoxylin-
eosin staining needed to achieve a successful HIFU liver ablation? What is the role of new
markers of tissue viability (Enzyme histochemistry - nicotinamide adenine dinucleotide
phosphatediaphorase and succinic dehydrogenase)?
2. What is the optimal HIFU sonication regime to obtain a successful ablation?
3. Can the HIFU properties be adjusted such as to preserve the integrity of major vessels and
ensure parenchyma ablation within the ablation volume? Should major vessels be avoided in
the area of planned HIFU ablation?
4. Does the non-perfused volume represent a reliable parameter for successful ablation
assessment?
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10. CONCLUSIONS
 Laparoscopic liver resection is a favourable alternative to open resection for both
benign and malignant lesions. The rate of perioperative adverse events appears to
decrease compared with open resections.
 Laparoscopic resection is a favourable alternative to open liver resection for patients
with colorectal liver metastases both in regard to perioperative results and plausibly
for oncologic outcome. The observed actuarial survival values after laparoscopic
resection surpass the predicted survival analysed by major scoring systems in regard to
open resection.
 Laparoscopic repeat hepatic resections can be performed safely and with good results,
particularly in patients with prior laparoscopic resections.
 Laparoscopic liver resection for lesions located in posterosuperior segments represents
certain technical challenges. However, the appropriate adjustment of surgical
techniques, equipment and optimal patient positioning enables the laparoscopic
technique to provide safe and effective parenchyma-sparing resections for lesions
located in posterosuperior segments.
 A randomised study to finalise the observed benefits of laparoscopic technique both in
relation to perioperative morbidity and oncologic outcomes is warranted.
 Extracorporeal MR-guided HIFU ablation in the liver is a challenging ablation
modality due to the high vascularity of liver parenchyma.
 Further studies to develop and optimise MR-guided HIFU ablation of liver lesions. In
particular, the impact of the multi-cycle sonication protocol, issues of functional
analysis of irreversible tissue damage and power-dependent threshold to cavitation
onset require further studies.
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12. ERRATA
Paper 1:
 It should be 176 instead of 177 (page 34, section “Patients” of the abstract, line 2; and
page 36, subsection “Intraoperative results” of section “Results”).
 It should be “115 Cases of single resection” instead of “114 Cases of single resection”,
“23 Cases of 2 concomitant resection” instead of “24 Cases of 2 concomitant
resections” and “176 Laparoscopic liver resections” instead of “177 Laparoscopic liver
resection” (page 36, Figure 2)
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Abstract
Background Totally laparoscopic liver resection of lesions
located in the posterosuperior segments is reported to be
technically challenging. This study aimed to deﬁne whether
these technical difﬁculties affect the surgical outcome.
Methods A total of 220 patients underwent laparoscopic
liver resection during 244 procedures from August 1998 to
December 2010. The patients who underwent primary
minor single liver resection for malignant tumors affecting
either posterosuperior segments 1, 7, 8, and, 4a (group 1) or
anterolateral segments 2, 3, 5, 6, and 4b (group 2) were
included in the study. Seventy-ﬁve procedures found to be
eligible for the study, including 28 patients in group 1 and
47 patients in group 2. Intraoperative unfavorable incidents
were graded on the basis of the Satava approach and
postoperative complications were graded in agreement
with the Accordion classiﬁcation.
Results The operative time (median, 127 min) and blood
loss (median, 200 ml) were equivalent in the two groups.
The rates for blood transfusions and intraoperative acci-
dents did not differ statistically between the groups. A
tumor-free margin resection was achieved in 94.7% of the
procedures, equivalently in both groups. The postoperative
course was similar in the two groups. Postoperative com-
plications developed in 2 cases (7.1%) in group 1 and 2
cases (4.3%) in group 2 (p = 0.626). The median hospital
stay was 2 days in both groups.
Conclusions Laparoscopic liver resection for lesions
located in posterosuperior segments represents certain
technical challenges. However, appropriate adjustment of
surgical techniques and optimal patient positioning enables
the laparoscopic technique to provide safe and effective
parenchyma-sparing resections for lesions located in both
posterosuperior and anterolateral segments.
Keywords Anterolateral segments  Laparoscopic liver
resection  Posterosuperior segments
Treatment of pathologic liver lesions is a fast-developing
area within current surgical practice [1]. In the early 1990s,
Reich et al. [2] and Gagner et al. [3] reported the ﬁrst cases
of laparoscopic liver resection. Since that time, the feasi-
bility and safety of this procedure have been documented in
several reports [4–19]. Despite tremendous advancement in
the ﬁeld of laparoscopic hepatobiliary surgery related to
both operative techniques and instrumentation, most lapa-
roscopic liver resections still are mainly performed for
easily accessible lesions [20].
Totally laparoscopic liver resection of posterosuperior
segments are reported to be technically challenging [21].
Establishment of a good outcome after laparoscopic liver
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and Other Interventional Techniques 
resection of lesions located in posterosuperior segments
could stimulate a wider application of this patient friendly
technique worldwide [22]. We aimed to deﬁne whether
these technical difﬁculties affect clinical outcome in the
expert hepatobiliary center.
Materials and methods
Patients
Rikshospitalet is a referral center for hepatobiliary proce-
dures. A total of 220 patients underwent laparoscopic liver
resection during 244 procedures from August 1998 to
December 2010 at the Oslo University Hospital, Rikshos-
pitalet. Our general experience and application of laparo-
scopic liver resections in the treatment of patients with
colorectal liver metastases was reported earlier [14, 23].
Patients who underwent primary minor liver resection of
malignant tumors affecting either posterosuperior segments
1, 7, 8, and 4a (group 1) or anterolateral segments 2, 3, 5, 6,
and 4b (group 2) were included in this study (Fig. 1). To
ensure an appropriate comparison between these two
groups of interest, the study excluded patients with benign
lesions; patients who underwent either hemihepatectomy,
left lateral lobectomy, or combined liver ablation proce-
dures; patients who simultaneously underwent another
major laparoscopic operation; and patients with lesions
affecting both anterolateral and posterosuperior segments.
Seventy-ﬁve procedures were found to be eligible for the
study, including 28 patients in group 1 and 47 patients in
group 2.
The indications for laparoscopic liver resection were
similar to those for open liver resection with respect to
preoperative assessment of liver function, type of liver
resection, and postoperative care. The majority of liver
tumors in both groups were colorectal metastases
(Table 1). The patient demographic data were similar in
the two groups (Table 2).
We used uniﬁed criteria to grade perioperative adverse
events. Intraoperative unfavorable incidents were graded
on the basis of the Satava approach to surgical error
evaluation (Table 3) and postoperative complications were
graded in agreement with the Accordion classiﬁcation
(Clavien-Dindo-Strasberg classiﬁcation) [23–27].
The standard preoperative investigations included liver
imaging (spiral computed tomography [CT] and contrast
ultrasonography as routine, and magnetic resonance
imaging [MRI] and positron emission tomography [PET]-
CT if required), chest imaging (plain X-ray or CT from
2005), and clinical biochemistry.
The patients received perioperative subcutaneous low-
molecular-weight heparin. Intravenous anesthesia was
used. At the beginning of surgery, bupivacaine hydro-
chloride was injected at the trocar port sites. Postoperative
analgesia consisted of a nonsteroidal antiinﬂammatory
drug and intravenous paracetamol. Intravenous opioids,
mainly by means of patient-controlled analgesia pump,
were given if additional analgesia was required. Postop-
erative opioid administration was registered from the ﬁrst
postoperative day. The patients were encouraged to
mobilize early and resume feeding as soon as it was tol-
erated. Tumor size was measured after specimen ﬁxation in
formaldehyde during the histopathologic analyses of the
resected specimens.
For patients discharged to a local hospital, information
about the postoperative course was retrieved and incorpo-
rated into the analyses of morbidity and hospital stay.
Fig. 1 Schematic view of liver
segments. The continuous black
line indicates a conventional
division of the liver to
posterosuperior segments 1, 7,
8, and 4a and anterolateral
segments 2, 3, 5, 6, and 4b
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Perioperative mortality was deﬁned as death within
30 days or before hospital discharge.
Techniques
The extent of liver resection was not altered by the appli-
cation of laparoscopic techniques. The surgical technique
has been described in detail previously [14].
To reach the most problematic segments (7 and 8), four
laparoscopic port sites usually were needed (Fig. 2). The
patient’s right abdominal side was elevated up to between
45 and 60. Usually, 12-mm port sites were used to enable
application of a wide range of laparoscopic instruments and
devices. Patient positioning and trocar placement should be
carefully adjusted to the tumor location and patient
constitution.
The ﬁrst port site was established by Edwin’s techniques
on the pararectal line 10 cm below the costal arch [28].
This port site was applied as the main site for a 30 lapa-
roscope. In very difﬁcult cases (e.g., when the quality of
the liver parenchyma prevented adequate mobilization of
the right lobe), a ﬂexible laparoscope (HD EndoEYE LTF-
VH; Olympus, Tokyo, Japan) was used.
After a concise evaluation of the abdominal wall in the
area of the intended trocar placement, two other trocars
were established lateral to the initial port site. The most
lateral trocar was positioned immediately anterior to the
right paracolic line to ensure a maximal posterior approach.
These port sites were applied as main sites for the surgical
handling of instruments. One additional port site was
established in the medioclavicular line about 5 cm below
the costal arch. This site was used mainly for variable
Table 1 Representation of
indications for surgery
Group 1 (n = 28) Group 2 (n = 47) Total (n = 75)
Metastatic tumors 28 43 71
Colorectal adenocarcinoma 24 36 60
Anal squamous cell carcimoma 1 1 2
Pancreatic glucagonoma 1 – 1
Pancreatic adenocarcinoma – 1 1
Lung adenocarcinoma 1 1 2
Melanoma (eye) 1 1 1
Carcinoid – 2 1
Malignant hemangiopericytoma – 1 1
Primary liver tumors: – 4 4
Hepatocellular carcinoma – 3 3
Cholangiocarcinoma – 1 1
Table 2 Patient characteristics
Parameters Group 1 (n = 28) Group 2 (n = 47) p Value Total (n = 75)
Age: years (range) 68 (43–82) 62 (35–88) 0.155 65 (35–88)
ASA score: n (range) 2 (2–3) 3 (1–4) 0.111 2 (1–4)
Female/male 16/12 20/27 0.242 36/39
Previous laparotomy: n (%) 22 (78.6.1%) 39 (83.0%) 0.636 62 (82.7%)
Data are presented as median (range) or number (%)
Table 3 Grading of unfavorable intraoperative incidents on the basis of the Satava approach to surgical error evaluation; adapted for liver
surgery
Grade Deﬁnition of intraoperative incidents
1 Incidents managed without change of operative approach and without further consequences for the patient. It includes perforations of
adherent or adjacent organs, minor change in intraoperative tactics, and cases with blood loss exceeding the normal range
(corresponding to blood loss exceeding 1,000 ml in case of liver resection)
2 Incidents with further consequences for the patient. It includes cases requiring limited resection of intraoperatively injured organs or
cases with blood loss appreciably more than the normal range. (It corresponds to blood loss exceeding 2,000 ml in case of liver
resection). It also includes cases requiring conversion to an open approach
3 Incident leading to signiﬁcant consequences for the patient
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application of a ﬁve-blade liver retractor or for division of
the anterior portion of the coronary ligament.
After division of adhesions due to previous abdominal
surgery, the liver was thoroughly examined using laparo-
scopic ultrasonography with Doppler function. For expo-
sure of lateral lesions in segment 8 and all lesions in
segment 7, the posterior portion of the right lobe was fully
mobilized. The right liver was lifted anteriorly by the liver
retractor, and both the right triangular ligament and the
coronary ligament were properly divided. The right liver
was meticulously dissected away from the caval vein
upward to the right hepatic vein (approach to segments 7
and 8), and in selected cases, the middle hepatic vein (in
case of approach to lesions in the most cranial part of
segment 8) were visualized.
The short hepatic veins were transected by clips or
Ligasure (Covidien, Norwalk, CT, USA). The resected
liver was removed in one piece through an enlarged
umbilical port incision using a 15-mm pouch (EndoCatch;
U.S. Surgical Corporation, Norwalk, CT, USA).
Statistical analysis
The major treatment outcomes were compared between
groups 1 and 2. The data are presented as median (range) or
number (percentage). Fisher’s exact test or Pearson’s chi-
square test was applied to compare proportions between
groups as appropriate. For comparison of continuous
variables, the Mann–Whitney U test was used.
The overall survival for patients with colorectal liver
metastases was evaluated. The log-rank test was applied for
comparison of survival between groups.
The median follow-up period was 18 months (range,
6–56 months) in group 1 and 26 months (range,
Fig. 2 Approach to segment 8.
A, B Computed tomography of
a tumor in segment 8 with a
vein branch in proximity
requiring attention.
C Dissection. D Extracted
specimen resulting from
parenchyma-sparing resection.
E Flexible laparoscope.
F Trocar positioning
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5–121 months) in group 2 (p = 0.176). Follow up status
(i.e., patient survival and tumor recurrence in the liver) was
ﬁnally veriﬁed in May 2011.
Results
No conversions to open surgery occurred in either of the
studied groups. The types of resections are presented in
Table 4.
The operative time and blood loss were equivalent in the
two groups (Table 5). The rate of blood transfusions and
unfavorable intraoperative accidents did not differ statis-
tically between the groups. One intraoperative accident
occurred in group 1: a case of immoderate intraoperative
bleeding (1,700 ml, managed laparoscopically) in a patient
with colorectal metastasis in segment 8 (Satava grade 1).
Three intraoperative accidents occurred in group 2: a case
of minor perforation to the small bowel during surgery
(immediately sutured laparoscopically) in a patient with
colorectal metastasis in segments 5 and 6 (Satava grade 1),
a case of immoderate intraoperative bleeding (2,000 ml,
managed laparoscopically) in a patient with colorectal
metastasis in segments 5 and 4b (Satava grade 1), and a
case of immoderate intraoperative bleeding (2,500 ml,
managed laparoscopically) in a patient with liver cirrhosis
and hepatocellular carcinoma in segments 2 and 3 (Satava
grade 2). Neither of the groups had perioperative mortality.
The median tumor size was similar in the two groups.
No signiﬁcant difference in weight or dimensions of the
resected liver specimen was observed. Two cases in each
group had involvement of tumor tissue in the resection. For
one additional case in each group, the resection margin was
negative but less than 1 mm. A tumor-free margin resec-
tion was achieved totally in 94.7% of the procedures of
both groups (Table 6). The minimal distance from the
resection line to the tumor tissue was signiﬁcantly shorter
in group 1 (median, 3 mm) than in group 2 (median,
8 mm).
The postoperative course did not differ statistically
between the studied groups (Table 5). On the day of the
operation, 70 (93.3%) of the 75 patients began to drink (26
of the 28 patients in group 1 and 44 of the 47 patients in
group 2). All the patients in both groups started to consume
a solid diet on the ﬁrst postoperative day. All the patients
were transferred from the postoperative intensive care unit
to the ordinary patient ward on the day of the operation.
Only 14 (50%) of the 28 patients in group 1 and 21 (44.7%)
of the 47 patients in group 2 required postoperative opioid
administration.
Two postoperative complications (7.1%) developed in
group 1: biliary leakage managed by percutaneous drainage
in a patient with colorectal metastasis in segments 7, 8, and
4a (readmitted for development of abscess, treated by
antibiotics) and liver abscess in the area of liver resection
managed by percutaneous drainage in a patient with pan-
creatic glucagonoma in segment 4a. Two complications
(6.4%) developed in group 2: bleeding at a trocar site of a
patient with colorectal metastasis in segment 3 controlled
by suture with the patient under local anesthesia and
pneumonia and intraabdominal seroma (percutaneously
drained) in a patient with colorectal metastasis in segments
5 and 4b.
In an additional case, diagnostic laparoscopy was
applied on postoperative day 2 due to unconﬁrmed suspi-
cion (occasioned by a sharp rise in C-reactive protein) of
biliary leakage in a patient with metastasis of anal squa-
mous cell carcinoma. The patient recovered uneventfully
and was discharged on postoperative day 5. All postoper-
ative complications corresponded to grade 3 of the
Accordion classiﬁcation.
The median postoperative hospital stay was 2 days in
both groups. Of the 75 patients, 68 (90.7%) were dis-
charged to their private homes (25 of the 28 patients in
group 1 and 43 of the 47 patients in group 2), whereas a
smaller number were transferred to a local hospital, another
hospital department, or a patient hotel for convalescence.
Tumor recurrence in the liver developed in 8 (28.6 %) of
the 28 patients in group 1 after a median of 7 months
(range, 4–8 months), and in 16 (34%) of the 47 patients in
group 2 after a median of 7 months (range, 2–25 months).
The data on postoperative liver recurrence and overall
survival did not differ statistically between the two groups
(p = 1.000 and 0.332 respectively).
Table 4 Representation of resection types
Segments No. of cases
Group 1 (n = 28)
7 13
8 7
4a 3
1 2
7 and 8 2
7, 8, and 4a 1
Group 2 (n = 47)
3 11
6 11
5 5
4b 5
2 3
5 and 6 5
5 and 4b 4
2 and 3 2
3 and 4b 1
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Discussion
Video laparoscopy has greatly changed the practice of
contemporary surgery, conferring several beneﬁts includ-
ing minimal damage to the abdominal wall, faster recovery,
fewer wound complications, and improved cosmetic
results. Despite early skepticism concerning laparoscopic
liver resection, it currently is accepted generally as a fea-
sible alternative to open resection, also for cancer [29–31].
The current study demonstrated that laparoscopic liver
resection can be performed safely for lesions located in both
the anterolateral and posterosuperior segments by an experi-
enced surgical team. We had a low rate of perioperative
adverse events (a 5.3% rate for intraoperative unfavorable
accidents by the Satava approach and a 5.3% rate for post-
operative complications by the Accordion classiﬁcation), and
no conversion or mortality occurred in the analyzed groups.
Despite their relatively early introduction in 1992, lap-
aroscopic techniques in liver surgery have not spread
worldwide as broadly as, for example, laparoscopy for
cholecystectomy [29, 30]. The majority of hepatobiliary
centers perform only open surgery for liver lesions. In
centers performing laparoscopic liver resection, operations
for lesions located in posterosuperior segments, which
considered to be so-called ‘‘difﬁcult segments’’, are largely
retained for open surgery.
For tumors located in segments 7 or 8, nonanatomic
liver resection or right posterior sectionectomy is prefera-
ble to right hemihepatectomy because it preserves the liver
parenchyma. However, these procedures are more chal-
lenging technically. Although only a small volume of liver
parenchyma usually is removed in a nonanatomic liver
resection, these resections in segments 7 and 8 are tech-
nically difﬁcult because exposure of deeply located lesions
is intricate, and the transection plane can be rounded or
angled [9, 19, 32]. Hanging techniques implying mobili-
zation of the right liver lobe and dissection along the caval
vein and up between the oriﬁce of the right and the middle
hepatic veins enabling to hang the right liver lobe could be
of major assistance (personal communication, Dr. I. S.Tait,
Dundee, UK).
In our series, the laparoscopic approach to posterosu-
perior segments was not associated with signiﬁcant difﬁ-
culties or increased morbidity. This perception is supported
equally by both intra- and postoperative outcomes for
resections of anterolateral and posterosuperior liver seg-
ments. Appropriate adjustment of trocar placement, a
ﬂexible laparoscope, extensive mobilization of the right
liver lobe, and adequate use of the gravity force are of great
help in such cases. In our experience, the availability of
several high-resolution large monitors in the operative
theater enabling surgeons to view not only intraoperative
Table 5 Surgical outcomes
Group 1 (n = 28) Group 2 (n = 47) p Value Total (n = 75)
Intraoperative parameters
Intraoperative incidents: n (%) 1 (3.6) 3 (6.4) 1.000 4 (5.3)
Operative time: min (range) 125 (50–336) 130 (50–315) 0.891 127 (50–336)
Blood loss: ml (range) 200 (\50–1,700) 200 (\50–2,500) 0.849 200 (\50–2,500)
Blood transfusions 1 (3.6) 4 (8.5) 0.645 5 (6.7)
Postoperative parameters: n (%)
Postoperative complications: n (%) 2 (7.1%) 2 (4.3) 0.626 4 (5.3)
Postoperative ﬁrst oral intake of ﬂuids: postoperative day (range) 0 (0–1) 0 (0–1) 0.899 0 (0–1)
Postoperative ﬁrst oral intake of solid food: postoperative day (range) 1 (0–1) 1 (0–1) 0.128 1 (0–1)
Postoperative opioid requirements: days (range) 0.5 (0–3) 0 (0–2) 0.849 0 (0–3)
Postoperative stay: days (range) 2 (1–9) 2 (1–7) 0.551 2 (1–9)
Data are presented as median (range) or number (%)
Table 6 Histopathologic dataa
Parameter Group 1 (n = 28) Group 2 (n = 47) p Value Total (n = 75)
Tumor-free margin resection: n (%) 26 (92.9) 45 (95.7) 0.626 53 (94.7)
Minimal distance from resection line to tumor tissue: mm (range) 3 (0–13) 8 (0–30) 0.003 5 (0–30)
Largest tumor size: mm (range) 24 (6–80) 25 (7–75) 0.549 25 (6–80)
Weight of resected specimen: g (range) 38 (5–174) 52 (7–270) 0.635 44 (5–270)
Largest dimension of resectat: mm (range) 60 (25–90) 65 (25–120) 0.359 63 (25–120)
a Data are presented as median (range) or number (%)
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ultrasonography but also preoperative imaging including
three-dimensional reconstruction of crucial anatomic
structures (vessels and bile ducts) was of major help
(Fig. 3). This further perks up intraoperative navigation
and thus may play an important role in laparoscopic liver
surgery, especially in the case of tumors located in pos-
terosuperior segments [33, 34].
The minimal distance from resection line to tumor tissue
was the only parameter that differed signiﬁcantly between
the studied groups. With regard to malignant liver lesions,
we have always aimed to achieve resection with a sufﬁ-
ciently safe resection margin with respect to tumor loca-
tion. However, the observed phenomenon may occur due to
a poorer exposition of the operative ﬁeld during the
approach to tumors located in posterosuperior segments.
This has led to increased concern with regard to possible
vascular or biliary injury. Thus, the surgeon was con-
strained to perform resection closer to the tumor margin to
prevent the additional risk while retaining a secure free
margin.
In our series, this phenomenon did not lead to a higher
rate of tumor-involved resection margins, to a higher rate
of recurrence in the liver, or to a poorer survival in patients
with resections of lesions located in posterosuperior
segments.
Thoracoscopic access to approach segments 7 and 8 is
suggested [35]. The thoracoscopic approach is associated
with a longer operative time and opening of the thoracic
cavity, consequently leading to increased risk of compli-
cations [36, 37]. This could indicate that application of the
thoracoscopic approach is not impeccable. A recent pub-
lication from Japan stated that the authors had switched
Fig. 3 Operative room
environment. A Imaging with
preoperative computed
tomography. B Imaging with
three-dimensional liver
reconstruction
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from the thoracoscopic to the laparoscopic approach for
resection of lesions in segment 8 due to lack of appreciable
beneﬁts [38].
We used a totally laparoscopic rather than a hand-
assisted approach as used by many others [39, 40]. With
some other surgeons, we believe that the hand-assisted
method or hybrid techniques have a limited role [9]. These
techniques supply a tactile sensation that is lacking during
laparoscopy. However, this approach requires a larger
incision, which reduces the beneﬁts of minimally invasive
surgery. Besides, fatigue in the inserted hand and air
leakage represent drawbacks of the hand-assisted method
[41]. However a handport could be applied in very chal-
lenging situations and tumor locations when the surgeon
does not achieve signiﬁcant progress in the procedure or
feels himself not fully conﬁdent without tactile control of
resection.
The hand-assisted technique was applied in only two
cases to facilitate extra-challenging resections in group 1
(7.1%). None of the cases in group 2 required use of the
hand-assisted technique. The decision to establish a hand-
port was made during the procedure based on intraproce-
dural circumstances to reduce an expected unreasonably
long operative time in case of application of the totally
laparoscopic approach. The handport was established
before liver mobilization in one case and after liver
mobilization in another case.
Intraoperative ultrasonography could partly substitute
for the lacking tactile sensation during totally laparoscopic
resection. Therefore, its application during laparoscopic
liver resection is mandatory to ensure adequate tumor
identiﬁcation and margin control [42, 43].
Theoretical premises and experimental studies have led
to anxiety among clinicians concerning the potential risk
for gas embolism during laparoscopic liver resection,
which has been especially highlighted with regard to pos-
terosuperior segments. This argument also has been used
by supporters of hand-assisted techniques [44, 45]. How-
ever accumulated world experience has shown that this risk
has been greatly overestimated [46, 47].
As for open surgery, bleeding and biliary leakage were
regarded as the most serious complications in both groups
[48]. However, high-tech surgical equipment has consid-
erably contributed to reducing the hazard of such compli-
cations [49]. We experienced adequate hemostatic control
by means of modern surgical equipment in both patient
groups. The postoperative course was equal in the two
groups. The median duration of postoperative stay was
only 2 days. The vast majority of patients started to con-
sume ﬂuids on the day of the operation, and all the patients
started to consume solid food on the ﬁrst operative day in
both groups.
Conclusion
Laparoscopic liver resection for lesions located in postero-
superior segments represents a certain technical challenge in
contrast to anterolateral segments. However, appropriate
adjustment of surgical techniques and patient positioning
suited to the particular tumor location enables the laparo-
scopic technique to provide safe and effective parenchyma-
sparing resections for lesions located in both posterosuperior
and anterolateral segments. We recommend wide applica-
tion of laparoscopic techniques for lesions located in pos-
terosuperior segments for centers that have mastered
laparoscopic liver resection of anterolateral segments with a
high degree of conﬁdence. This will enable provision of the
best currently available treatment for a large number of
patients, will favor parenchyma-sparing techniques, and will
deﬁnitively contribute to further promotion of a patient-
friendly concept of minimally invasive surgery.
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